Annual Conference and Exhibition Programme - British ...

Annual Conference and 

Exhibition Programme 

28 – 30 May 2012, 

Manchester Central, 

Manchester 

Promoting excellence in cardiovascular care

Introduction 

Welcome to Manchester and the BCS Annual Conference 2012. We have a high quality 

educational programme lined up with something for everyone! The format is the same 

as last year and the programme is organised into ‘tracks’. 

Highlights of the Programme 

Training Day, Monday – 

> Covering topics from the curriculum not often covered at courses elsewhere 

e.g. clinical genetics, cardiac syndromes, the heart and systemic disease 

> SAC session – all a Trainee needs to know about work based assessments and 

workforce predictions 

Education for Revalidation (E4R) track – 

> Educational sessions mapped to the cardiology curriculum (covered in 3-5 

year cycle) 

> ESC guidelines: pregnancy / heart disease and dyslipidaemia 

> Top 10 trials 

Affiliated Groups track – 

> BCCA, BCIS (case presentations and a live MDT meeting), BSE, BSH and Heart 

Rhythm UK dedicated sessions 

Imaging track – 

> Covering all imaging modalities plus the popular ‘read with the experts’ session 

> William Zoghbi lecture at ACC session on ‘The future of cardiovascular imaging’ 

Clinical Science / Translational Research track (supported by the British Heart 

Foundation, BHF) – 

> Cutting edge sessions with an eminent national and international faculty 

followed by lively abstract presentations at the poster stands. With the 

generous support of the BHF, the top 12% of abstracts in each category will 

receive a travel grant. Highest scoring abstracts for each category marked by a 

gold star 

> Young Research Workers Prize – 5 are shortlisted and will battle it out in front of 

a tough panel to win the highly regarded YRWP! 

Basic Science Track (BAS/BSCR – supported by the BHF) – 

> With an eminent national and international faculty and an imaging theme across 

the subspecialties from Basic Science to Clinical Application 

BCS sessions include – 

> Named Lectures by Alec Vahanian and Rory Collins 

> ‘Carry on in the cath lab’: a film illustrating non-technical skills training through 

simulation (made by the BCS in conjunction with the BLT simulation centre) 

> Working group reports: ACHD interventions and Acute Cardiac Care Units 

> Themed sessions (see below) 

Linked days 

> SCST: with a programme suitable for cardiac physiologists and the cath 

lab team 

> BACPR and BANCC: with an exercise, prevention and rehabilitation theme

HCP (UK) – for the first time we welcome our patients to this linked day dedicated to 

the memory of David Geldard MBE 

The Theme for 2012: Exercise in healthy hearts and heart disease 

With the Olympics this summer, Tuesday 29 May will be the BCS Sports Day. Alongside 

the main programme, the day will include dedicated BCS sessions relating to training (from 

‘MAMiL’ to elite), sudden cardiac death and exercise in certain cardiac conditions. The 

Arena in the Exhibition will have educational demonstrations on exercise during the breaks. 

Don’t miss Olympic medalist Rebecca Romero on Tuesday lunchtime. Pitch yourself against 

Chris Hoy on a simulator in the Arena and help us raise money for CRY with the Cyclathon 

in the Central Foyer. Greg Whyte will be setting the pace. You could win tickets to the 

Olympics or an iPad! Go to http://www.bcs.com/crycyclathon for more information. We are 

also hosting an event for local school children outside the Conference to educate the next 

generation on a healthy lifestyle. 

Exhibition, Arena and Simulators 

Please visit the Exhibition during the breaks. This year, we are providing more education 

around the stands with case presentations, interpretation of data, ‘How to…’ posters. Come 

and test your knowledge and visit the stands too. The arena activities are within the Exhibition 

area. Simulation based learning will soon be part of revalidation and training and this year we 

have a wider range of simulators than ever before, including a new station to help refine your 

dissection and suturing skills. Sign up for sessions at the Simulator Area or online. 

Social events 

An important part of the Conference is the opportunity to network both professionally 

and socially. 

Annual Dinner – Tuesday 29 May, 7:30pm in the Alexandra Suite, Midland Hotel 

The Annual Dinner is a must: following a drinks reception, infiltrated by magicians, and the 

presentations, dinner will be accompanied by wine and a string quartet. We are delighted to 

have an Olympian, sports scientist and celebrity trainer to entertain us for the after dinner 

speech. Reserve your seat and table at the registration desk. Your table will have a chance 

to win a magnum of champagne. 

Tea Party! – Wednesday 30 May, 3pm in the Exhibition 

It’s our 90th Birthday, so come and join us for a celebration ‘tea party’ on the Wednesday 

afternoon in the Exhibition. See how the world and cardiology have changed over the 

last nine decades. See how much we have raised for CRY and who has won the prizes 

including Olympic tickets and an iPad. 

Keeping updated 

Don’t forget to follow us on Twitter @BritishCardioSoc or use #bcs2012. Look out for our 

daily e-magazine and check out the website www.bcs.com for summaries and webcasts of 

key sessions at the Conference. 

Finally, ‘thank you’ to our Exhibitors and to the British Heart Foundation for their support. 

Thank you to the webcasters and a special thanks to the Programme Committee and the 

BCS staff who help make it all happen! 

I hope you enjoy the BCS Annual Conference 2012! 

Sarah Clarke 

Chair of the Programme Committee 

BCS Vice-President Education & Research 

2012 Annual Conference and Exhibition p3

BCS CourSeS in 2012-13 

BCS & Mayo Clinic “Cases, Controversies & Updates” in 

Cardiovascular Medicine 

For Cardiologists and Senior Trainees 

15 – 17 October 2012 

Following its successful introduction in 2011, this course has been adapted and 

expanded to meet the revalidation needs of Cardiologists. Key faculty from the BCS 

and Mayo Clinic will provide an in-depth look at difficult cases, current controversies 

and latest updates in Cardiovascular Medicine. 

BCS & RCP Cardiology Update for General Physicians 

10 October 2012 

An annual update for General Physicians covering cardiac drugs, 

stable angina and other essential topics for those covering Cardiology in the 

community. Visit the RCP website to register for this course 

www.rcplondon.ac.uk 

National Training Day 

26 November 2012 

For UK Cardiology Trainees, this is the second National Training Day and will 

address topics from the Cardiology Curriculum that may not be covered elsewhere. 

A Year in Cardiology 

14 December 2012 

Providing a succinct review of the years’ hot topics with particular emphasis on 

clinical practice and a round-up of key developments in the sub-specialties. This 

symposium is a must for Consultants and Trainees wishing to keep abreast of major 

advances in Cardiology. 

BCS & Mayo Clinic Cardiology Review Course 

4 – 8 March 2013 

Matched to the Cardiology Curriculum, this 5 day course gives a 

great overview of current cardiovascular medicine. Suitable for Cardiology Trainees, 

Specialist Doctors and Consultants wishing to refresh their knowledge. 

See www.bcs.com for details or email courses@bcs.com 

to register your interest. 

All courses held at Royal College of Physicians, London. 

ViSiT ThE 

BCS.CoM STAND 

(No.60) To 

Book ToDAY

Contents 

Introduction ................................................................................... 2 

General Information ....................................................................... 6 

Conference ............................................................................. 6 

Registration ........................................................................ 6 

CPD ................................................................................... 6 

Speaker Preview Room ...................................................... 6 

The Programme and Tracks ............................................... 6 

Sponsored Symposia ......................................................... 7 

Sports Theme and Sports Day ........................................... 7 

Webcasting and Revalidation Questions ............................ 7 

Annual Dinner .................................................................... 7 

CRY Cyclathon .................................................................. 8 

British Heart Foundation..................................................... 8 

Travel Training Grants and BCS Travel Bursaries ............... 8 

BCS Organisers Contact at the Conference ....................... 8 

Exhibition ................................................................................ 9 

Lunch, breaks and 90th Birthday Tea Party........................ 9 

Wi-Fi and Internet Stations ................................................. 9 

Clinical & Scientific Exchange Area ..................................... 9 

Education in the Exhibition ................................................. 9 

Simulator Training .............................................................. 9 

Sports Arena – Exercise demonstrations 

and Industry Soundbites .................................................. 11 

Meet the experts .............................................................. 12 

Abstracts / Posters .......................................................... 12 

Educational Posters ......................................................... 12 

BCS.com stand ............................................................... 13 

The BCS ............................................................................... 14 

Officers of the Society ...................................................... 14 

Programme Committee .................................................... 15 

Abstract / Poster Discussants .......................................... 16 

Abstract Markers ............................................................. 19 

Affiliated Groups of the BCS ............................................ 20 

Programme at a glance – Monday 28 May ................................. 22 

Monday 28 May 2012 – Programme details ........................... 24 

Programme at a glance – Tuesday 29 May ................................. 32 

Tuesday 29 May 2012 – Programme details........................... 34 

Programme at a glance – Wednesday 30 May ........................... 42 

Wednesday 30 May 2012 – Programme details ..................... 44 

Floor Plans and Exhibitors .......................................................... 54 

Exhibition Floor Plan ............................................................... 56 

Conference Floor Plan ............................................................ 58 

Exhibition Guide ..................................................................... 66 

Exhibitors index – Company and Stands .......................... 66 

Exhibitors Listing .............................................................. 68 

Abstracts and Posters ................................................................. 80 

Abstract / Poster Guide .......................................................... 80 

Abstract / Poster Listing – Title and Lead Author ................... 82 

Young Research Workers’ Prize ....................................... 82 

Abstracts and Posters ..................................................... 83 

BAS/BSCR Abstracts and Posters ................................. 106 


General Information 

Conference 

Registration 

CPD 

Registration is in the Central Foyer of Manchester Central. Registration 

desks will be open at the following times: 

Sunday 27 May – 16:00 to 18:00 

Monday 28 May – 08:00 to 17:30 

Tuesday 29 May – 08:00 to 17:30 

Wednesday 30 May – 08:00 to 15:00 

Delegate badges 

Badges must be worn at all times to gain admission to the Conference 

and Exhibition hall. 

The Conference is registered with the Royal College of Physicians 

for CPD. CPD credits are accrued at 1 per hour of attended lectures 

(maximum 18 credits). 

The British Society of Echocardiography award 3 BSE re-accreditation 

credits (CME) for attendance at the whole Conference. 

Speaker Preview Room 

The Speaker Preview Room is located in the Central Foyer. Speakers 

should report to the Speaker Preview Room a minimum of three hours 

before their session. 

The Programme and Tracks 

The Programme is designed around ‘tracks’ plus named lectures, 

dedicated themed BCS sessions, sponsored symposia and Affiliated 

Group linked days (see introduction on page 2). The ‘at a glance’ 

programme for each day is colour coded to help you create your own 

educational itinerary.

Sponsored Symposia 

The BCS would like to thank the following Exhibitors who 

will be hosting sponsored symposia in the Auditorium at the 

following times: 

Monday 09:00 to 10:00 Sanofi – Multaq (dronedarone): Confidence, 

Consensus and Continuation 

Monday 17:30 to 19:00 Boehringer Ingelheim – Cardiology, SPAF 

and the new oral anticoagulants: Beyond the headlines 

Sports Theme and Sports Day 

The Conference has a sports theme this year and Tuesday has been 

designated as our ‘Sports Day’. There are dedicated BCS sessions 

covering sports medicine. The Arena activities at lunchtime include 

Olympic Gold Medallist Rebecca Romero as the elite athlete pitched 

against a Cardiologist as we learn about exercise physiology. The 

Cyclathon (see page 8) will be raising money for CRY. There will be 

a Chris Hoy cycling simulator in the Arena on Tuesday: see if you 

can beat him! Independent of the Conference, the BCS is holding an 

educational event for local school children around lifestyle and activities 

for a healthy heart. 

Webcasting and Revalidation Questions 

Webcasts for most of the sessions will be available on www.bcs.com. 

For the E4R track, revalidation questions will be posted on the site. A 

certificate will be issued if 60% of the questions are answered correctly. 

Annual Dinner 

The Annual Dinner takes place on Tuesday evening, 29 May. It will be 

like no other! The evening features a champagne reception, magicians, 

chance to win a magnum of champagne and a 3 course dinner with 

wine accompanied by strings from the Royal Northern College of 

Music. Prizes and awards will be given by the President. We are 

delighted to have a guest after dinner speaker – Olympian, sports 

scientist and celebrity trainer, Professor Greg Whyte. 



CRY Cyclathon 

Throughout the Conference, Cardiac Risk in the Young (CRY) is holding 

a fundraising Cyclathon. The Cyclathon is being held in the Central 

Foyer, near Registration. Delegates are invited to book a five minute 

slot to cycle as far as they can on the static bike. To book a slot and 

make a donation please go to the stand or go online (www.bcs.com/ 

crycyclathon). There are prizes to be won including Olympic tickets, 

an iPad plus more! The total distance cycled and prize winners will be 

announced in the Sports Arena at the BCS 90th Birthday Tea Party 

at 14:30 on Wednesday. The monies raised will go towards the CRY 

‘myheart support network’ which offers information, support and help 

to young people coping with the diagnosis of a heart condition. Please 

help us raise money for charity whilst having some fun! 

British Heart Foundation 

The British Heart Foundation (BHF) will be holding a drinks reception on 

Monday 18:30-19:30 in The Gallery. Thanks to the generous support 

of the BHF, the BCS has been able to give a number of travel awards 

to Abstract Presenters to contribute to the cost of attending the BCS 

Annual Conference. 

Travel Training Grants and BCS Travel Bursaries 

We are grateful to the Merck, Sharp and Dohme for their support in 

providing travel grants for Trainees, Nurses and Cardiac Physiologists to 

assist them in attending the BCS Annual Conference. 2012 is the final 

year that BCS will offer these travel grants as they have been replaced 

by the newly established BCS Travel Bursaries. 

The BCS established the Travel Bursary Scheme for attendance at 

national and international meetings. A number of Bursaries have been 

awarded to facilitate attendance at the BCS Annual Conference 2012. 

For further information on the BCS Travel Bursary Scheme please see 

www.bcs.com. 

BCS Organisers’ Contact at the Conference 

The Organisers’ Office is located in the Exhibition Hall, see maps on 

page 56-59. The contact telephone number for the Organisers’ Office 

during the Conference is 0161 827 7650 ext. 2250.

Exhibition 

The Exhibition is open from 10:00 on Monday 28 May. See from page 54 

onwards for details of the Exhibition floor plan and this years’ Exhibitors. 

Lunch, Breaks and 90th Birthday Tea Party 

Lunch bags are provided free of charge for all. These will be available 

from the Red, White and Blue Lounge areas in the Exhibition. Free 

tea and coffee are also available from these lounge areas during the 

breaks. The BCS will host a 90th Birthday Tea party, in the Exhibition, 

during the Wednesday afternoon break. 

Wi-Fi and Internet Stations 

Free Wi-Fi access is available throughout the venue using the 

password BCS2012. There are a number of free internet stations 

positioned around the venue, kindly sponsored by Roche. Free internet 

access is also available at the BCS.com stand (number 60). 

Clinical & Scientific Exchange Area 

The Clinical & Scientific Exchange Area, located in the Exhibition, 

provides a quiet and confidential environment for clinicians and 

scientists to meet privately, away from the stands. The area consists 

of an enclosed lounge and a small number of private meeting rooms 

which can by hired for meetings. To hire part of this area please report 

to the receptionist in the Clinical & Scientific Exchange Area. 

Education in the Exhibition 

The following educational activities are taking place in the Exhibition Hall: 

Simulator Training 

Simulator training sessions are available in diagnostic angiography 

(including radial access), percutaneous coronary intervention 

(simple and complex), transcatheter aortic valve implantation, 

electrophysiology (including trans-septal puncture and coronary 

sinus lead placement) and transthoracic and transoesophageal 

echocardiography (this year with pathology). There is also a Basic 

Surgical Skills station offering training in dissection and suturing 

techniques. To book a simulator training session please go to the 

BCS website, www.bcs.com. 



A limited number of supervised ‘drop-in’ sessions for group simulator 

training will be available at the end of each day. These do not need to 

be booked and will take place on: 

Monday: 15:30 to 17:30 

Tuesday: 15:30 to 17:30 

Wednesday: 13:30 to 15:00 

All pre-arranged sessions will last 30 minutes and will consist of oneto-one 

tutorial with an experienced trainer. The training will follow some 

key objectives (see website) but will be tailored to the experience of the 

individual and suitable for all Trainees and Consultants. 

The BCS will forward a Certificate of Completion shortly after the 

Conference. The certificate will detail the specific training given. 

PCI simulator 

A range of interventional techniques including basic angiography 

and vascular access (aimed at Junior SpRs), general PCI (aimed 

at intermediate SpRs), and more complex PCI including IVUS and 

bifurcation lesions (aimed at senior SpRs and Consultants) can be 

covered. A simulator dedicated to managing PCI complications is also 

available. The EP simulator covers trans-septal puncture. 

TAVI 

Aimed at senior SpRs and Consultants, this is a Corevalve simulator but 

will cover general principles of a TAVI procedure. 

EP including trans-septal puncture 

Simulator training in electrophysiology will cover a range of techniques 

including RV and atrial lead placement, LV lead placement, ICD and 

pacemaker interrogation and programming. There are also simulators 

for trans-septal puncture. 

ECHO 

Four echocardiography simulators will be available for either transthoracic 

or transoesophageal simulation. We will provide training on handling of the 

TTE or TOE probe, image acquisition and assessment of the mitral valve, 

aortic valve, atria and left ventricle.

Basic Surgical Skills for Cardiologists 

For the first time this year we will also be running surgical skills 

workshops. These will provide a thorough grounding in the latest 

surgical materials and skills relative to the implantation of cardiac 

rhythm devices and include dissection and suturing. 

The BCS is grateful to Boston Scientific, CAE Healthcare, 

Cordis, HeartWorks, Medtronic, Mentice and Terumo for providing 

the simulators. 

Sports Arena – Exercise demonstrations and 

Industry Soundbites 

Take a seat for the clinical and exercise demonstrations plus short 

industry presentations, ‘Soundbites’, taking place on the Sports Arena, 

located in the Exhibition. The timetable is as follows: 

Monday 12:15 to 12:45 Challenges in Sports Cardiology – Part 1 

Prof Sanjay Sharma 

Monday 14:35 to 14:55 Soundbite: Low dose thrombin-inhibition – 

Emerging role in secondary prevention 

of ACS 

Prof John Cleland (Bayer Healthcare) 

Tuesday 10:05 to 10:25 Soundbite: My ACS Experience 

By a Patient (AstraZeneca UK Limited) 

Tuesday 12:15 to 12:45 CPEX testing. From ‘Average’ Joe to 

Olympic Gold 

‘Average’ Joe is pitched against Rebecca 

Romero, Olympic Gold medalist 

Dr John Buckley 

Tuesday 14:35 to 14:55 Soundbite: Setting the PACE 

(Prevention And Cardiovascular Care) 

Dr John Buckley (Abbott Healthcare 

Products Ltd) 

Wednesday 10:05 to 10:25 Challenges in Sports Cardiology – Part 2 


Wednesday 14:35 to 14:55 CRY with results of the Cyclathon 

Dr Steve Cox 



On Tuesday, Sports Day, a ‘Chris Hoy’ cycling simulator will be available 

in the Arena for delegates to race against the Olympic and World 

Champion! Please sign up for a ride at the Arena. See who can get the 

closest time…or beat him! The simulator will be supervised. 

Meet the Experts 

The following stands will be hosting educational ‘Meet the Expert’ with: 

Bayer Healthcare (Stand 34) – ‘Oral anticoagulation practicalities’ with 

Dr Will Lester, Prof Gordon McInnes and Dr Ganesh Subramanian. 

Monday, Tuesday, Wednesday, during breaks. 

Abstracts / Posters 

Each day BCS abstracts will be on display in the poster area in the 

Fitzroy Atrium which is at the back of the Exhibition, adjacent to the 

Fitzroy Theatre. They will be presented to discussants in the last 30 

minutes of certain Clinical Science / Translational Research Track and 

Imaging Track sessions of the programme. Please see page 80 for 

further details and a listing of all the abstracts. 

Educational Posters 

The Programme Committee have produced a number of educational 

posters and these are positioned around the Exhibition – a list of 

locations is included in the delegate bag. Answers to the Quiz Posters 

(posters 1-4) are available at www.bcs.com and at the BCS.com stand 

(stand number 60). 

1. Quiz no. 1: ECG tracings 

2. Quiz no. 2: Pacemaker tracings 

3. Quiz no. 3: ECG tracings 

4. Quiz no. 4: Implantable Defibrillator tracings 

5. How to gain ‘axillary vein’ access using fluoroscopic guidance 

6. Minimising shock therapy in primary prevention patients: 

evidence-based ICD programming 

7. New Ghent criteria for systemic involvement in 

Marfan syndrome 

8. Pulsed levosimendan in heart failure 

9. LV non compaction and pregnancy

10. Congenitally corrected Transposition of the Great 

Arteries (ccTGA) 

11. Congential Heart Disease Imaging quiz 

12. Spontaneous coronary artery dissection 

13. How to…Balloon Aortic Valvuloplasty 

14. How to…Fractional Flow Reserve (FFR) 

15. How to…Intra-Aortic Balloon Pump 

16. How to…IVUS and OCT 

17. How to…Pericardiocentesis 

18. How to…Primary PCI 

Thanks to Dr Leisa Freeman, Dr Phil MacCarthy and Dr Arthur Yue, of 

the Programme Committee, for coordinating the Educational Posters. 

BCS.com stand 

Please visit the BCS.com stand (stand number 60) for information on 

BCS, our membership, our educational courses running throughout 

the year and online courses available for our members. You can also 

try your hand at the Revalidation for Education tracks’ online Multiple 

Choice Questions or simply get easy internet access. Answers to the 

Quiz Posters 1-4 will also be accessible at the BCS.com stand. 

The organisers / publishers accept no responsibility for statements made in 

this publication or for any errors or omissions which may have occurred. All 

information in this Guide is correct up to the time of going to print. 


The BCS 

Officers of the Society 

President Prof Keith Fox 2009 – 2012 

President Elect Dr Iain Simpson 2011 – 2012 

Honorary Secretary Dr Bernard Prendergast 2011 – 2014 

Vice-President Clinical Standards Dr Simon Ray 2010 – 2013 

Vice-President Corporate 

and Financial Affairs Prof Derek Yellon 2009 – 2012 

Vice-President Corporate 

and Financial Affairs Elect Dr Steve Holmberg 2011 – 2012 

Vice-President Education 

and Research Dr Sarah Clarke 2011 – 2014 

Vice-President Training Dr Jim Hall 2010 – 2013 

Non-executive Trustee Mr Graham Meek 2007 

Non-executive Trustee Mr Nigel Turner 2008 

Non-executive Trustee Mr John Carrier 2009 

Non-executive Trustee Prof Sir Roger Boyle 2011

Programme 

Committee 

The Programme Committee is responsible for developing the 

Programme and other activities at the Annual Conference. The BCS 

would like to thank the Chair and the Committee for all their hard work 

in delivering a high quality and varied Programme for 2012. 

Programme Committee members: 

S Clarke (2003) (Chair 2011) 

C Burrell (2010) 

R Choudhury (2011) 

KAA Fox (2008) 

L Freeman (2011) 

J Hall (2009) 

D Hausenloy (2010 

R Henderson (2010) 

C Knight (2007) 

P MacCarthy (2011) 

J Pearson (BHF) 

B Prendergast (2006) 

S Ray (2009) 

J Rudd (2010) 

N Samani (2009) 

I Simpson (2006) 

A Wragg (2011) 

D Yellon (2004) 

A Yue (2011) 

F Durrant (BCS) 

M-L Pitts (BCS) 

S Yeats (BCS) 


Abstract / Poster 

Discussants 

The poster presentations are embedded into the last 30 minutes of certain 

sessions of the Clinical Science / Translational Research Track and the Imaging 

Track. Please see the Programme at a Glance for poster sessions. For more 

information see the Abstracts / Posters section and the Abstract / Poster Guide 

(from page 80). The Poster sessions will be held in the Fitzroy Atrium. Authors will 

present their poster to a pair of expert discussants. 

The Programme committee would like to thank the Discussants (listed below). 

Monday 28 May Posters Session 

Dr Hugh McIntyre 1 – 4 6 

Prof Lipbun Tan 1 – 4 6 

Dr Alison Seed 5 – 8 6 

Dr Leisa Freeman 5 – 8 6 

Dr Lynne Warner Stevenson 9 – 12 6 

Prof Theresa McDonagh 9 – 12 6 

Dr Ahmet Fuat 13 – 15 6 

Dr David Dutka 13 – 15 6 

Dr Paul Kalra 16 – 18 6 

Dr Suzanna Hardman 16 – 18 6 

Dr Robert Henderson 19 – 22 16 

Dr David Smith 19 – 22 16 

Dr Ajay Jain 23 – 25 16 

Dr James McLenachan 23 – 25 16 

Dr Derek Harrington 26 – 28 16 

Dr Philip MacCarthy 26 – 28 16 

Dr Daniel Blackman 29 – 31 16 

Dr Sagar Doshi 29 – 31 16 

Dr Mark Gunning 32 – 35 16 

Dr Neil Swanson 32 – 35 16 

Dr David Hesketh-Roberts 36 – 38 16 

Dr Douglas Fraser 36 – 38 16 

Dr Ghada Mikhail 39 – 42 16 

Prof Simon Redwood 39 – 42 16 

Dr Charles Knight 43 – 45 16 

Dr Joseph Mills 43 – 45 16 

Dr Denise Braganza 46 – 48 16 

Dr Jim Hall 46 – 48 16

Tuesday 29 May Posters Session 

Dr Arthur Yue 49 – 51 23 

Dr Timothy Betts 49 – 51 23 

Dr Derek Connelly 52 – 54 23 

Dr Mark Hall 52 – 54 23 

Dr Andrew Grace 55 – 57 23 

Dr Samuel Asirvatham 55 – 57 23 

Dr Edward Rowland 58 – 60 23 

Dr William Stevenson 58 – 60 23 

Dr Douglas Skehan 61 – 63 23 

Dr Stephen Furniss 61 – 63 23 

Dr Derick Todd 64 – 67 23 

Dr Prada Kanagaratnam 64 – 67 23 

Dr Timothy Irvine 68 – 70 32 

Prof Kim Greaves 68 – 70 32 

Dr Andrew Mitchell 71 – 74 32 

Prof David Newby 71 – 74 32 

Dr Andreas Baumbach 75 – 77 32 

Prof John Chambers 75 – 77 32 

Dr Peter Golledge 78 – 80 32 

Dr Rod Stables 78 – 80 32 

Wednesday 30 May Poster Session 

Dr James Rudd 81 – 83 43 

Dr Rosemary Rusk 81 – 83 43 

Dr Gerry McCann 84 – 87 43 

Dr Saul Myerson 84 – 87 43 

Dr Mark Westwood 88 – 90 43 

Dr Matthais Schmitt 88 – 90 43 

Dr Giles Roditi 91 – 93 43 

Dr John Greenwood 91 – 93 43 

Dr Rachael James 94 – 97 43 

Dr Roger Bury 94 – 97 43 

Dr Francisco Leyva-Leon 98 – 100 43 

Dr Nathan Manghat 98 – 100 43 


Abstract / Poster 

Discussants 

Dr Charles Peebles 101 – 103 43 

Dr Jim Newton 101 – 103 43 

Prof Jeremy Pearson 104 – 106 44 

Prof Shu Ye 104 – 106 44 

Prof Ajay Shah 107 – 109 44 

Prof Manuel Mayr 107 – 109 44 

Dr Stephen Wheatcroft 110 – 112 44 

Prof Michael Marber 110 – 112 44 

Dr Sandosh Padmanabhan 113 – 115 44 

Prof Robin Choudhury 113 – 115 44 

Dr Christopher Newman 116 – 118 44 

Dr Fiona Green 116 – 118 44 

Dr Sean Davidson 119 – 121 44 

Prof Derek Yellon 119 – 121 44 

Dr Simon Corbett 122 – 124 50 

Prof Colin Berry 122 – 124 50 

Dr Martyn Farrer 125 – 127 50 

Dr Mrinal Saha 125 – 127 50 

Dr Philip Adams 128 – 131 50 

Dr William Penny 128 – 131 50 

Dr Mark de Belder 132 – 134 50 

Prof Anthony Gershlick 132 – 134 50 

Dr Mark Dancy 135 – 137 57 

Prof Bryan Williams 135 – 137 57 

Dr Andrew Epstein 138 – 141 57 

Dr Malcolm Walker 138 – 141 57 

Dr Leisa Freeman 142 – 145 57 

Dr Richard Anderson 142 – 145 57 

Dr Susan Connolly 146 – 148 57 

Prof Stefan Neubauer 146 – 148 57 

Dr Rajesh Kharbanda 149 – 151 57 

Dr Robert Henderson 149 – 151 57

Abstract Markers 

The Programme Committee wishes to acknowledge the generous 

time given for abstract selection by the following: 

Dr Philip Adams 

Dr Richard Anderson 

Dr Robert Bell 

Dr Colin Berry 

Dr Daniel Blackman 

Dr Lucy Blows 

Dr Roger Bury 

Dr Frank Casey 

Prof Keith Channon 

Dr Susan Connolly 

Prof Derek Connolly 

Dr Simon Corbett 

Prof Martin Cowie 

Dr Ian Cox 

Dr Mark Dancy 

Dr Sean Davidson 

Dr Sagar Doshi 

Dr David Dutka 

Dr Martyn Farrer 

Dr Ahmet Fuat 

Prof Anthony Gershlick 

Dr Simon Gibbs 

Dr Peter Golledge 

Prof Kim Greaves 

Dr Fiona Green 

Dr Mark Hall 

Dr Robert Hatrick 

Mr Marcus Haw 

Dr David Hesketh-Roberts 

Dr Adrian Ionescu 

Dr Tim Irvine 

Dr Ajay Jain 

Dr Rachel James 

Ms Catriona Jennings 

Dr Paul Kalra 

Dr Prapa Kanagaratnam 

Dr Raj Kharbanda 

Dr Edmund Ladusands 

Ms Andrea Manley 

Dr Gerry McCann 

Dr Hugh McIntrye 

Mr Scott McLean 

Dr Andrew Mitchell 

Dr Saul Myerson 

Dr Chris Newman 

Dr Jim Newton 

Dr Sandosh Padmanabhan 

Dr Liam Penny 

Ms Alison Pottle 

Dr Bernard Prendergast 

Mr Prakash Punjabi 

Prof Tom Quinn 

Dr Charles Redwood 

Dr Giles Roditi 

Dr Helen Routledge 

Dr Matthias Schmitt 

Dr Sanjay Sharma 

Dr Doug Skehan 

Dr David Smith 

Dr Neil Swanson 

Dr Bun Tan 

Dr Patricia Thomson 

Dr Derick Todd 

Dr Fiona Walker 

Dr Malcolm Walker 

Mrs Hannah Waterhouse 

Dr Clive Weston 

Dr Stephen Wheatcroft 

Dr Christopher Wren 

Dr Shu Ye 

Dr Arthur Yue 


Affiliated Groups 

of the BCS 

Name of Group President/Chair 

AA Arrhythmia Alliance T Lobban 

BACPR British Association for Cardiovascular J Jones 

Prevention & Rehabilitation 

BANCC British Association for Nursing in Cardiovascular Care S McLean 

BAS British Atherosclerosis Society M Bennett 

BCCA British Congenital Cardiac Association T Salmon 

BCIS British Cardiovascular Intervention Society S Redwood 

BJCA British Junior Cardiologists’ Association M Jelian 

BNCS British Nuclear Cardiology Society P Arumugam 

BSCI British Society of Cardiovascular Imaging R Bury 

BSCMR British Society of Cardiovascular Magnetic Resonance P Leyva 

BSCR British Society for Cardiovascular Research Y Alexander 

BSE British Society of Echocardiography G Lloyd 

BSH British Society for Heart Failure S Hardman 

HCP (UK) Heart Care Partnership K Timmis 

Heart Rhythm UK S Furniss 

SCST Society for Cardiological Science and Technology S Baxter

BSCMR 

H 

C P 

UK 

Heart Care Partnership 

(UK) 


Monday 28 May 2012 

The following key enables individual tracks to be identified throughout the Programme 

Training Day Imaging track Education for Revalidation 

track (E4R) 

Affiliated Group track BCS Sessions Clinical Science / Translational 

Research track (CS/TR) 

09.00 

– 

10.00 

Auditorium Exchange Hall Charter 2 

Sponsored Symposium: 

Sanofi 

Multaq ▼ (dronedarone): 

Confidence, Consensus and 

Continuation 

10.00 – 10.30 Exhibition Opens 

10.20 

– 

10.30 

10.30 

– 

12.00 

2 

Opening Ceremony 

E4R Track 

3 

Mitral Regurgitation: State of 

the Art 

AG Track – BSE 

4 

Should you be 

stressed? 

12.00 – 13.00 Break & Arena Activities in the Exhibition 

13.00 

– 

14.30 

E4R Track 

8 

Acute Coronary Syndromes – 

Essentials of Management 

14.30 – 15.00 Break 

15.00 

– 

16.30 

16.30 

– 

17.30 

17.30 

– 

19.00 

17.30 

– 

18.30 

E4R Track 

13 

Joint BCS/ACC session: 

the future of cardiovascular 

imaging, ACC highlights 

BCS Lecture 

18 

Thomas Lewis Lecture 

Sponsored Symposium: 

Boehringer Ingelheim 

Cardiology, SPAF and the new 

oral anticoagulants: Beyond the 

headlines 

AG Track - BSH 

9 

Acute Heart Failure – 

today and tomorrow 

AG Track – BCCA 

14 

Non-cardiac surgery 

in the patient with 

congenital heart 

disease 

1 

Training 

Key knowledge... 

Training 

5 

The Syndrome 

Session 

Training 

10 

SAC 

Training 

15 

The Heart in 

Systemic Disease

Programme at a glance 

Basic Science track 

(BAS/BSCR) 

Named Lectures Sponsored 

Symposia 

Fitzroy Theatre Charter 1 

CS/TR Track 

6 

Novel therapeutic interventions for heart failure 

Posters 

1-18 

CS/TR Track 

11.1 

Michael Davies Career Award 

13.00 – 13.30 

11.2 

New Frontiers in Regenerative Therapy 

13.30 – 14.30 

CS/TR Track 

16 

Novel interventions for treating 

cardiovascular disease 

Posters 

19-48 

Linked Day: SCST Linked Day: BACPR/BANCC 

Linked Day: Heart Care 

Partnership HCP (UK) 

BAS/BSCR 

7 

Functional Imaging Arrhythmogenic 

Substrates / Arrhythmias 

BAS/BSCR 

12 

Application of imaging techniques in heart 

failure research 

BAS/BSCR 

17 

BAS/BSCR Posters 

BAS/BSCR 

19 

John French Lecture 

2012 Annual Conference and Exhibition p23 

Monday 28th May

Monday 28th May 


Programme details 

09.00-10.00 Charter 2 Training 

1 Key knowledge ... 

Chairs: Dr Derek Harrington, Dr Iain Simpson 

Get the J point? 

Prof Michael Joy 

10.20-10.30 Auditorium 

The cardiopulmonary exercise test - intelligent interpretation 


Pharmacological stress in diagnostic tests 

Dr Eliana Reyes 

2 Opening Ceremony 

Prof Keith Fox 

10.30-12.00 Auditorium E4R 

3 Mitral Regurgitation: State of the Art 

Chairs: Dr Philip MacCarthy, Prof Alec Vahanian 

Anatomy, imaging and functional assessment 

Dr Bushra Rana 

When to intervene 

Dr Michael Bellamy 

How to intervene - clip, repair or replace? 

Mr Neil Moat 

10.30-12.00 Exchange Hall Affiliated Group - BSE 

4 Should you be stressed? 

Chairs: Dr Guy Lloyd, Prof Roxy Senior 

At the front door 

Prof Kim Greaves 

When out of breath 

Dr Grant Heatlie 

In hibernation 

Prof Mark Monaghan 

With a valve prosthesis 

Prof John Chambers


5 The Syndrome Session 

Chairs: Prof Bernard Clarke, Dr Sarah Clarke 

The Cardiorenal Syndrome 

Dr Mark Gunning 

Takotsubo Syndrome 

Dr Charles Knight 

Muscular Dystrophy and the Heart 

Dr Perry Elliott 

Syndrome X 

Prof Juan-Carlos Kaski 

10.30-12.00 Fitzroy Theatre CS/TR 

6 Novel therapeutic interventions for heart failure 

Chairs: Prof Andrew Clark, Prof Theresa McDonagh 

Vagal nerve stimulation for heart failure 

Dr Peter Schwartz 

Gene therapy for heart failure 

Dr Alexander Lyon 

Metabolic modulation for heart failure 

Prof Michael Frenneaux 

Posters: Heart Failure (1-18) 

10.30-12.00 Charter 1 Basic Science 

7 Functional Imaging Arrhythmogenic Substrates / 

Arrhythmias 

Chairs: Dr Andrew Grace, Prof Manuela Zaccolo 

Cyclic nucleotide signalling: in vivo imaging of intracellular 

signal transduction 

Prof Manuela Zaccolo 

Imaging structure and calcium release in the atria 

Dr Katharine Dibb 

Exciting Light: Optogenetics in Cardiac Muscle Physiology 

Dr Philipe Sasse 

Imaging and Cardiac Ablation 

Dr Samuel Asirvatham 


Monday 28th May




8 Acute Coronary Syndromes – Essentials of 

Management 

Chairs: Dr Christopher Burrell, Dr Mark de Belder 

Pathophysiology of acute coronary syndromes – how do 

these define clinical presentations? 

Prof Keith Channon 

How should risk stratification influence management in 

NSTEMI – did NICE get it right? 

Prof Keith Fox 

Optimising the management pathway for STEMI 

Dr James McLenachan 

13.00-14.30 Exchange Hall Affiliated Group - BSH 

9 Acute Heart Failure – today and tomorrow 

Chairs: Prof Henry Dargie, Dr Suzanna Hardman 

Acute Heart Failure – today’s outcomes 

Prof Theresa McDonagh 

Acute Heart Failure – today’s treatment 

Prof Andrew Clark 

Acute Heart Failure – tomorrow’s world 

Prof John Cleland 


10 SAC 

Chairs: Dr Jim Hall, Dr Ian Wilson 

Strategy for the best use of Workplace Based Assessments 

in Cardiology 

Dr Ian Wilson 

BJCA survey 2012 

Dr David Holdsworth 

Clinical Genetics for Cardiologists 

Dr Michelle Bishop 

Workforce projections for Cardiologists 2012 

Dr Jim Hall 

Open questions from the floor


11.1 Michael Davies Early Career Award 2011 and 2012 

Chairs: Prof Anthony Mathur, Prof Jeremy Pearson 

The effects of shear stress on endothelial activation and 

vascular inflammation 

Prof Paul Evans 

Reawakening embryonic mechanisms to repair the adult heart 

Dr Nicola Smart 

11.2 New Frontiers in Regenerative Therapy 

Chairs: Dr Jonathan Hill, Prof Jeremy Pearson 

Pre-Clinical Research – Epicardial-derived stem cells for acute 

myocardial infarction 

Dr Nicola Smart 

Phase 1/2 Clinical Research – Autologous Fat Derived Cells 

(ADVANCE Trial) and Allogeneic Selected Mesenchymal Stem 

Cells (AMICI Trial) 

Dr Henricus Duckers 

Phase 3 Clinical Research – Autologous Unselected Bone 

Marrow Mononuclear Cells (BAMI trial) 

Prof Anthony Mathur 


12 Application of imaging techniques in heart failure 

research 

Chairs: Prof Colin Berry, Prof Godfrey Smith 

New nanoscale technique to study cAMP/cGMP localisation 

in cardiovascular tissue 

Dr Julia Gorelik 

Local control in EC coupling 

Dr Mark Cannell 

Multi-photon imaging of contractile failure 

Dr Rachel Myles 

Nox4-dependent protective effects in the heart 

Prof Ajay Shah 






13 Joint BCS/ACC session: the future of cardiovascular 

imaging, ACC highlights 

Chairs: Prof Keith Fox, Dr William Zoghbi 

The Future of Cardiovascular Imaging in Healthcare 

Dr William Zoghbi 

Highlights of the ACC 2012 – Innovations 

Dr John Harold 

Highlights of the ACC 2012 – Intervention 

Dr Dipti Itchhaporia 

Highlights of the ACC 2012 – Late breaking trials 

Dr William Bommer 

15.00-16.30 Exchange Hall Affiliated Group - BCCA 

14 Non-cardiac surgery in the patient with congenital 

heart disease 

Chairs: Dr Aiden Bolger, Dr Viakom Mahadevan 

Non-cardiac surgery in the patient with congenital heart 

disease-where and by whom? 

Dr Kate English 

Pre-operative assessment – what the anaesthetist needs to 

know from the Cardiologist 

Dr Debbie Turfrey 

Safe anaesthesia and post-operative care 

Dr Ravi Gill 

Management of a pregnant patient with congenital heart 

disease at delivery 

Dr Sara Thorne 


15 The Heart in Systemic Disease 

Chairs: Dr Christopher Burrell, Dr Alison Calver 

Iron Overload 

Dr Lisa Anderson 

Amyloidosis 

Dr Simon Dubrey 

Collagen Vascular Diseases 

Dr Gerry Coghlan


16 Novel interventions for treating cardiovascular 

disease 

Chairs: Dr Nicholas Banner, Dr Charles Knight 

Renal denervation and stimulation for hypertension 

Dr Horst Sievert 

The Parachute procedure for post-MI heart failure 

Dr Michael Mullen 

Total artificial heart as a bridge to transplantation 

Mr Stephen Tsui 

Posters: Interventional Cardiology (19-48) 


17 BAS/BSCR Posters 

Chair: Prof Martin Bennett 

16.30-17.30 Auditorium BCS Named Lecture 

18 Thomas Lewis Lecture 

Introduced by: Dr Bernard Prendergast 

Thanked by: Dr Iain Simpson 

A journey through percutaneous valve intervention 

Prof Alec Vahanian 

17.30-18.30 Charter 1 BAS/BSCR 

19 John French Lecture 

Chair: Prof Martin Bennett 

Matrix metalloproteinases and atherosclerosis: get the 

right balance 

Dr Jason Johnson 





Sponsored Symposiums 

09.00-10.00 Auditorium Sponsored Symposium 

Sanofi 

Multaq ▼ (dronedarone): Confidence, Consensus and 

Continuation 

Chair: Prof John Camm 

The importance of maintaining sinus rhythm in patients with AF 

Prof John Camm 

Real world experience of Multaq in the right patient 

Prof Paulus Kirchhof 

17.30-19.00 Auditorium Sponsored Symposium 


Cardiology, SPAF and the new oral anticoagulants 

(NOACs): Beyond the headlines 

Chair: Dr Sarah Jarvis 

Audience facilitator: Dr Gethin Ellis 

The very latest evidence for the NOACs in SPAF 

Prof Gregory Lip 

The potential role for the NOACs in cardioversion and ablation 

Dr Derick Todd 

The new orals in practice: learnings from across the pond 

Dr Michael Ezekowitz



Tuesday 29 May 2012 



track (E4R) 



08.30 

– 

10.00 


AG Track – BCIS 

20 

MDT Live 

10.00 – 10.30 Break 

10.30 

– 

12.00 

BCS Session 

26 

MAMILs (Middle Aged Men In 

Lycra) 

E4R Track 

21 

Prevention is better 

than Cure 


13.00 

– 

14.30 

BCS Session 

29 

Sudden cardiac death in sport 

14.30 – 15.00 Break 

15.00 

– 

16.30 

16.30 

– 

17.30 

BCS Session 

35 

Exercise and heart disease 

BCS Lecture 

40 

BCS Lecture supported by the 

Joy Edelman Legacy 

E4R Track 

30 

Pregnancy and heart 

disease 

E4R Track 

36 

How to 

19.30 – Late BCS Annual Dinner 

Imaging Track 

22 

Bicuspid aortic 

valve and 

coarctation 

Imaging Track 

31 

Pericardial disease 

Imaging Track 

37 

Diabetic heart 

disease: 

mechanisms, 

detection and 

treatment



(BAS/BSCR) 


Symposia 

Fitzroy Theatre Charter 1 Charter 4 

CS/TR Track 

23 

20 year anniversary of the Brugada 

syndrome: from bedside to cell back to 

bedside 

Posters 

49-67 

27 

Young Research Workers Prize 

CS/TR Track 

32 

Tissue engineering for mending a 

broken heart 

Posters 

68-80 


BAS/BSCR 

24 

Joint BAS/BSCR Young 

Investigators Award 



BAS/BSCR 

33 

Molecular and cellular 

imaging in myocardial 

infarction and regeneration 

Joint BCS/BAS/BSCR 

Lecture 

38 

Emerging techniques for 

evaluation of atherosclerotic 

plaque 

HCP (UK) 

25 

Finding the voice 

HCP (UK) 

28 

Listening to the 

Voice 

HCP (UK) 

34 

Supporting the 

Voice 

HCP (UK) 

39 

Passing on the 

Voice 

2012 Annual Conference and Exhibition 

p33 

Tuesday 29th May

Tuesday 29th May 



08.30-10.00 Auditorium Affiliated Group - BCIS 

20 MDT Live 

Chairs: Dr Philip MacCarthy, Dr Bernard Prendergast 

Case 1 – Aortic stenosis with co-existent coronary disease 

Dr Douglas Muir 

Moderator: Dr Philip MacCarthy 

Panelist – intervention: Dr Rod Stables 

Panelist – surgery: Mr Olaf Wendler 

Panelist – imaging: Dr Bushra Rana 

Panelist – non-intervention: Dr David Sprigings 

Data Summariser: Dr Daniel Blackman 

Case 2 - Multi-vessel coronary artery disease in the 

acute setting 

Dr Narbeh Melikian 

Moderator: Dr Bernard Prendergast 

Panelist – intervention: Dr Nick West 

Panelist – surgery: Mr Paul Waterworth 

Panelist – imaging: Dr Gerry McCann 

Panelist – non-intervention: Dr Gethin Ellis 

Data Sumariser: Dr Charles Knight 

08.30-10.00 Exchange Hall E4R 

21 Prevention is better than Cure 

Chairs: Dr Peter Schofield, Prof David Wood 

NICE management of hypertension – new guideline review 

Prof Bryan Williams 

How to manage hyperlipidaemia – beyond statins (for the 

intolerant!) 

Prof Kausik Ray 

The weight of the 21st century – obesity, diet and exercise 

Prof Nicholas Finer

08.30-10.00 Charter 2 Imaging 

22 Bicuspid aortic valve and coarctation 

Chairs: Dr John Thomson, Prof William Zoghbi 

Genetics and morphology of bicuspid aortic valve and 

coarctation 

Dr Elspbeth Brown 

Imaging of the aorta – beyond dimensions 

Dr Alex Pitcher 

Native coarctation: stent or surgery? 

Dr Paul Clift 

Long-term follow up and screening of relatives – who 

needs imaging? 

Dr Catherine Head 


23 20 year anniversary of the Brugada syndrome: From 

bedside to cell back to bedside 

Chairs: Dr Tim Betts, Dr Pier Lambiaise 

Pre-clinical models of the Brugada syndrome 

Dr Andrew Grace 

Advanced approaches of endovascular electrophysiological 

mapping 

Dr Arthur Yue 

Catheter Ablation for Ventricular Fibrillation Storms 

Dr William Stevenson 

Posters: Cardiac Rhythm Management (49-67) 


24 Joint BAS/BSCR Young Investigators Award 

Chairs: Dr Yvonne Alexander, Prof Martin Bennett 


Tuesday 29th May



08.30-10.00 Charter 4 HCP (UK) 

25 Finding the voice 

Chair: Mr Ken Timmis 

The Doctor will see you now 

Dr Iain Simpson 

The Safe and Sustainable message and how it affects users 

Ms Suzie Hutchinson 

Involving patients and carers in developing health information 

Dr Felicity Astin 

Identifying, recruiting & maintaining members – what is 

needed? 

Mrs Trudie Lobban 

Questions and answers 

10.30-12.00 Auditorium BCS Session 

26 MAMILs (Middle Aged Men In Lycra) 

Chairs: Prof David Crossman, Dr Leonard Shapiro 

Training with trainers 

Prof Richard Davison 

It’s all in the mind 

Dr Amanda Gatherer 

Food for Fuel 

Mr Graeme Close 

Getting back on track after injury 

Mr Ian Horsley 

10.30-12.00 Fitzroy Theatre BCS Session 

27 Young Research Workers Prize 

Chairs: Prof Keith Fox, Prof Michael Marber 

Judges: Prof Martin Bennett, Prof Henricus Duckers, Dr 

Gavin Murphy, Dr Matthias Nahrendorf, Prof Godfrey Smith

10.30-12.00 Charter 4 HCP (UK) 

28 Listening to the Voice 

Chair: Dr Jane Flint 

The customer is always right – clinical and research 

perspectives 

Dr Bernard Prendergast 

The political approach to patients and carers 

Rt Hon Tony Lloyd MP 

How can patients share their experiences to promote better 

and more sustained lifestyle changes 

Prof Patrick Doherty 

Panel discussion with questions and answers 


29 Sudden cardiac death in sport 

Chairs: Dr Ian Cox, Prof Graham Stuart 

Sudden cardiac death 


Pre-participation cardiovascular screening 

Prof Greg Whyte 

The Million Dollar Medical 

Dr Abbas Zaidi 

ARVC vs. athletes heart 

Dr Andre La Gerche 


30 Pregnancy and heart disease 

Chairs: Dr Catherine Head, Dr John Thomson 

Structural heart disease in pregnancy 

Dr Fiona Walker 

Cardiac emergencies in pregnancy 

Dr Dawn Adamson 

Management of peri-partum cardiomyopathy 

Dr Kate English 


Tuesday 29th May




31 Pericardial disease 

Chairs: Prof Simon Ray, Dr Rick Steeds 

Pericardial disease - aetiology, pathology and disease 

mechanisms 

Dr Patrick Gallagher 

Constriction, restriction, neither? Understanding the 

physiology 

Dr Nicholas Brooks 

Optimal imaging strategy – what is required? 

Dr Dana Dawson 

Treatment strategies in pericardial disease: drugs, surgery 

or nothing? 

Dr Colin Forfar 


32 Tissue engineering for mending a broken heart 

Chairs: Dr Carolyn Carr, Dr Alexander Lyon 

Tissue-engineered heart valves 

Prof Alex Seifalian 

Tissue-engineered platforms for heart repair 

Prof Ken Suzuki 

Tissue-engineered blood vessels 

Dr Christopher Breuer 

Posters: Valve disease / pericardial disease / 

cardiomyopathy (68-80) 


33 Molecular and cellular imaging in myocardial infarction 

and regeneration 

Chairs: Prof Robin Choudhury, Dr Farouc Jaffer 

Elucidation of myocardial healing: lessons from 

multimodal imaging 

Dr Matthias Nahrendorf

MRI for comprehensive characterisation in mouse 

models of myocardial ischaemia 

Dr Jurgen Schneider 

MR spectroscopy, oxygen imaging, myocardial 

metabolism and emerging techniques 

Prof Stefan Neubauer 

13.00-14.30 Charter 4 HCP (UK) 

34 Supporting the Voice 

Chair: Mrs Suzie Hutchinson 

BHF Hearty Voices training programme and patient 

empowerment 

Dr Michael Knapton 

How a local training programme can empower patients and 

carers to work in partnership with healthcare colleagues to 

deliver changes across cardiovascular services 

Mrs Carol Reilly 

How supporting carers can ensure everyone wins 

Dr Moira Fraser 

The experiences of a young patient 

Ms Evie Fairman 

Question and Answer session 


35 Exercise and heart disease 

Chairs: Dr Christopher Burrell, Prof Sanjay Sharma 

Athletes and Atrial Fibrillation 

Prof John Camm 

Exercise guidelines for hypertrophic cardiomyopathy 

Dr Michael Papadakis 

Exercise guidelines for congenital heart disease 

Dr John Thomson 

Case study: benefits of exercise in heart failure - 

the exercise prescription 

Mrs Samantha Breen 


Tuesday 29th May




36 How to 

Chairs: Dr Bernard Prendergast, Dr Charles Knight 

How to use a cardiac genetics service 

Dr Houman Ashrafian 

How to assess cardiac risk prior to non-cardiac surgery 

Prof Roxy Senior 

How to prevent and manage endocarditis in 2012 

Dr Richard Watkin 


37 Diabetic heart disease: mechanisms, detection and 

treatment 

Chairs: Prof Henry Dargie, Dr David Hesketh-Roberts 

Fundamental mechanisms of diabetic cardiomyopathy 

Dr Garth Cooper 

Myocardial function and structure in the diabetic heart 

Prof Michael Frenneaux 

Imaging of ischaemia in diabetes - what’s optimal? 

Prof Avijit Lahiri 

Revascularisation in diabetics – how to decide CABG vs PCI 

Dr Nicholas West 

15.00-16.30 Charter 1 BCS Joint Session 

38 

Joint BCS/BAS/BSCR 

Emerging techniques for evaluation of atherosclerotic 

plaque 

Chairs: Dr Matthias Nahrendorf, Dr James Rudd 

Near-infrared fluorescence approaches to imaging 

atherosclerosis and thrombosis 

Dr Farouc Jaffer

VH-IVUS in acute coronary syndromes 

Prof Martin Bennett 

Application of positron emission tomography for the 

assessment of novel therapies 

Dr James Rudd 

15.00-16.30 Charter 4 HCP (UK) 

39 Passing on the Voice 

Chairs: Prof Sir Roger Boyle, Dr Jane Flint 

Perspective and feedback (from questionnaire) on key issues 

from the Patient Voice 

Dr Jane Flint, Prof Sir Roger Boyle 

16.30-17.30 Auditorium BCS Named Lecture 

40 BCS Lecture supported by the Joy Edelman Legacy 

Introduced by: Prof Peter Weissberg 

Thanked by: Prof Keith Fox 

Changing cholesterol levels: past, present, future 

Prof Rory Collins 


Tuesday 29th May

Wednesday 30 May 2012 



track (E4R) 



08.30 

– 

10.00 


AG Track – BCIS 

41 

BCIS Cases 

E4R Track 

42 

Understanding 

Ventricular 

Tachycardia 

Imaging Track 

43 

Read with the 

experts 

Posters 

81-103 


10.30 

– 

12.00 

12.00 – 13.00 Lunch 

13.00 

– 

14.30 

AG Track – HRUK 

47 

Current issues within 

implantable devices 

BCS Session 

54 

Carry on in the Cath Lab! 

E4R Track 

48 

Specific Causes 

of Heart Failure: 

Cardiomyopathy 

Workshop 

53 AGM 

12.10 – 12.50 

E4R Track 

55 

Joint BCS/ESC 

session: Guidelines- 

Pregnancy and 

heart disease, 

Dyslipidaemias 

Imaging Track 

49 

Aortic Stenosis – 

new questions, new 

answers? 

Imaging Track 

56 

Hypertrophic 

cardiomyopathy 

14.30 – 15.00 Break & 90th Birthday Tea Party in the Exhibition 

15.00 

– 

16.30 

E4R Track 

60 

Top 10 Trials 

BCS Session 

61 

BCS points of view – 

working group reports



(BAS/BSCR) 


Symposia 

Fitzroy Theatre Charter 1 Charter 4 

CS/TR Track 

44 

MicroRNA as a novel therapeutic target 

for cardiovascular disease 

Posters 

104-121 

CS/TR Track 

50 

Myocardial reperfusion injury in 

PPCI patients: A neglected target (in 

conjunction with the ESC Working Group 

of Cellular Biology of the Heart) 

Posters 

122-134 

CS/TR Track 

57 

Interstitial myocardial fibrosis as a future 

therapeutic target for cardiac disease 

Posters 

135-151 


Lunch 

BACPR/BANCC 

45 

Parallels between the 

physiological management 

of the cardiac patient and 

the elite athlete 

BACPR/BANCC 

51 T 

echniques for assessing 

CVD risk and subsequent 

management of the 

individual patient’s lifestyle 

behaviour 

BACPR/BANCC 

58 

The world of CVD and 

epidemiology – Populationbased 

and Community 

interventions 

BACPR/BANCC 

62 

How to session: 

case-studies 



SCST 

46 

Physiology for 

Physiologists – 

ECG Education 

SCST 

52 



SCST Hot Topics 

SCST 

59 



Cath Lab Education 

SCST 

63 



Inherited Cardiac 

Conditions 


p43 

Wednesday 30th May

Wednesday 30th May 



08.30-10.00 Auditorium Affiliated Group - BCIS 

41 BCIS Cases 

Chair: Prof Simon Redwood 

Data presentations: Dr Rod Stables 

Panel: Dr Robert Henderson, Dr Bernard Prendergast, 

Dr Iain Simpson, Mr Christopher Young 

Patient with high calcium score and no symptoms 

Dr Mrinal Saha 

Unprotected left main stem stenosis with intermediate 

SYNTAX Score 

Dr Adrian Banning 

Severe asymptomatic mitral regurgitation 

Dr Robert Crook 

PCI in an elderly patient 

Dr Adam de Belder 


42 Understanding Ventricular Tachycardia 

Chairs: Dr Simon Fynn, Dr Edward Rowland 

Identification and classification of ventricular arrhythmias by 

aetiology, mechanism and electrocardiography 

Dr John Bourke 

When and how to investigate VEs and nsVT 

Dr André Ng 

Drug, device or ablation therapy – who gets what in 2012? 

Dr Stephen Furniss 


43 Read with the experts 

Chairs: Dr Charles Peebles, Dr Mark Westwood 

Multi-modality imaging case 

Dr Ceri Davies 


Dr Gareth Morgan-Hughes 


Dr John Greenwood


Dr James Moon 

Posters: Imaging (81-103) 


44 MicroRNA as a novel therapeutic target for 

cardiovascular disease 

Chairs: Prof Manuel Mayr, Prof Nilesh Samani 

MicroRNAs in cardiovascular health and disease 

Prof Manuel Mayr 

MicroRNAs and cardiac hypertrophy 

Prof Gianluigi Condorelli 

MicroRNAs as a therapeutic target for cardiovascular disease 

Dr Thomas Thum 

Posters: Basic Science (104-121) 

08.30-10.00 Charter 1 BACPR/BANCC 

45 Parallels between the physiological management of the 

cardiac patient and the elite athlete 

Chairs: Dr Christopher Burrell, Dr Sanjay Sharma 

Cardiopulmonary patient 

Dr John Buckley 

The elite athlete 

Prof Greg Whyte 

08.30-10.00 Charter 4 SCST 

46 Physiology for Physiologists – ECG Education 

Chairs: Dr Derek Rowlands, Mr David Richley 

The role of the limb leads – Who needs limb leads? 

Dr Philip Moore 

Making sense of the hexaxial reference system – QRS Axis: 

What’s that all about? 

Dr Derek Rowlands 

A structured approach to ECG Interpretation – Step by Step 

Mr Michael Blackwell 

Reverse Discussion: Questions to audience from 

the speakers 


Wednesday 30th May



10.30-12.00 Auditorium Affiliated Group – HR UK 

47 Current issues within implantable devices 

Chairs: Dr Nicholas Linker, Dr Adrian Morley-Davis 

Faulty leads – add, extract or ignore 

Dr Christopher Rinaldi 

Proper programming prevents poor performance – optimal 

set up of pacemakers, ICDs and CRT devices 

Dr David Fox 

MRI scans and implantable devices – safety, new 

technologies and patient selection 

Dr Amir Zaidi 


48 Specific Causes of Heart Failure: 

Cardiomyopathy Workshop 

Chairs: Dr Peter Cowburn, Prof Martin Cowie 

Dilated cardiomyopathy 1 – genotype, phenotype and 

diagnosis 

Dr Perry Ellliott 

Dilated cardiomyopathy 2 – achieving the best outcomes 

Dr Gerald Carr-White 

How to manage restrictive cardiomyopathy 



49 Aortic Stenosis – new questions, new answers? 

Chairs: Dr Guy Lloyd, Dr Bernard Prendergast 

How does aortic stenosis progress? 

Prof David Newby 

How can imaging modalities assess progression? 

Dr Marc Dweck 

How to risk stratify asymptomatic patients? 

Prof John Chambers 

Should we worry about myocardial fibrosis in aortic stenosis? 

Dr Gerry McCann


50 Myocardial reperfusion injury in PPCI patients: A 

neglected target (in conjunction with the ESC 

Working Group of Cellular Biology of the Heart) 

Chairs: Prof Michael Marber, Prof Derek Yellon 

Myocardial reperfusion injury: magnitude and relevance 

Dr Derek Hausenloy 

Detecting myocardial reperfusion injury in PPCI patients: 

role of CMR 

Dr Sven Plein 

Preventing myocardial reperfusion injury in PPCI patients 

Prof Michel Ovize 

Posters: Acute coronary syndromes (122-134) 

10.30–12.00 Charter 1 BACPR/BANCC 

51 Techniques for assessing CVD risk and subsequent 

management of the individual patient’s lifestyle 

behaviour 

Chairs: Prof Gill Furze, Dr Fran Sivers 

The use of the ‘heart age’ calculation 

Prof Rod Jackson 

Mars & Venus; different approaches to CVD behaviour change 

Damian Edwards 


52 Physiology for Physiologists – SCST Hot Topics 

Chairs: Mrs Su Baxter, Mrs Catherine Ross 

Debate: MSC will redefine the physiologists role 

Protagonist: Ms Joanne Forster 

Antagonist: Dr Brian Campbell 

AGM 

Mrs Su Baxter 

Professional integrity and ethics in physiology – Integrity: it’s 

a matter of Principle 

Ms Sophie Blackman 


Wednesday 30th May



12.10-12.50 Exchange Hall 

53 BCS AGM (BCS Members only) 

Chair: Prof Keith Fox 


54 Carry on in the Cath Lab! 

Chairs: Dr Sarah Clarke, Dr Jim Hall 

Moderator: Dr Christopher Saddler 

Part 1 – Black box in the Cath Lab 

Dr Rod Stables 

Part 2 – Film ‘Carry on in the Cath lab’. A team based 

simulation 

Panel: Dr Iain Simpson (Consultant), Dr Andrew Wragg 

(Consultant), Dr Daniel Bromage (Registrar), Ms Sarah Carson 

(Nurse), Mr Richard Walters (Physiologist) 


55 Joint BCS/ESC session: Guidelines – Pregnancy and 

heart disease, Dyslipidaemias 

Chairs: Prof Michael Böhm, Prof Keith Fox 

Pregnancy and heart disease – Guidelines 

Prof J Roos-Hesselink 

Pregnancy and heart disease – Implications and 

implementation 

Dr Sara Thorne 

Dyslipidaemia – Guidelines 

Prof David Wood 

Dyslipidaemia - Implications and implementation 

Prof John Deanfield 


56 Hypertrophic cardiomyopathy 

Chairs: Prof Michael Frenneaux, Dr John Greenwood 

Bridging the gap between genotype and phenotype – who 

needs genetic testing? 

Prof Hugh Watkins

Is this HCM? Differentiating from other pathologies 

Dr Rosemary Rusk 

Prognosis in HCM – what does imaging add? 

Dr Matthias Schmitt 

Therapy update 

Dr Perry Elliott 


57 Interstitial myocardial fibrosis as a future therapeutic 

target for cardiac disease 

Chairs: Prof Stefan Neubauer, Prof Ajay Shah 

The role of the myocardial interstitium in cardiac health 

and disease 

Prof Javier Diez 

Non-invasive detection and measurement of interstitial 

myocardial fibrosis 

Dr James Moon 

Guiding medical therapy by measuring interstitial myocardial 

fibrosis 

Prof Alan Struthers 

Posters: Stable IHD / Prevention / Hypertension / Lipids 

(135-151) 


58 The world of CVD and epidemiology – Population-based 

and Community interventions 

Chairs: Ann-Marie Johnson RN, Jennifer Jones MCSP 

‘Real-world’ examples of what can work and reflections on 

sustainability 

Prof Simon Capewell 

Life after the NHS CVD health checks – Prison health 

Jayne Swarbrick RN 

Life after the NHS CVD health checks – Tackling local health 

inequalities 

Gabriella Walker 


Wednesday 30th May




59 Physiology for Physiologists – Cath Lab Education 

Chairs: Mr John Hutchinson, Mr Ian Wright 

Cardiac Cycles and Associated Haemodynamics – 

Beat by Beat 

Miss Louisa Chick 

Cath Lab Calculations – Out with the Calculator 

Mr John Hutchinson 

Case Studies – Cath Lab Complexities 

Ms Sophie Blackman 

The IABP – Counterpulsation for the Nation 

Mr Ian Wright 


60 Top 10 Trials 

Chairs: Dr Charles Knight, Dr Bernard Prendergast 

Plumbing – Trial 1 

Intra-Aortic Balloon Pump in Acute Anterior Myocardial 

Infarction: CRISP AMI 

Dr Douglas Fraser 

Plumbing – Trial 2 

TAVI versus Surgery in High Risk Aortic Stenosis: PARTNER A 

Dr Jon Byrne 

Plumbing – Clinical Perspective 

Prof Simon Redwood 

Artwork – Trial 1 

CMR and SPECT for Diagnosis of Coronary Artery Disease: 

CE-MARC 

Dr Stam Kapetanakis 

Artwork – Trial 2 

Cardiac CT in Patients with Acute Chest Pain: ROMICAT II 

Dr Ceri Davies 

Artwork – Clinical Perspective 

Prof Roxy Senior 

Electrics – Trial 1 

Dronedarone in High Risk Permanent Atrial Fibrillation: 

PALLAS 

Dr Mark O’Neill

Electrics – Trial 2 

Case Selection for CRT According to QRS Duration: 

Meta-Analysis 

Dr Derek Connelly 

Electrics – Clinical Perspective 

Dr Chris Pepper 

Pump – Trial 1 

Left Ventricular Restoration Surgery in Ischaemic 

Cardiomyopathy: STICH 

Dr Carol Whelan 

Pump – Trial 2 

Autologous Bone Marrow Cells in Chronic Ischaemic Heart 

Failure: FOCUS 

Dr Jonathan Hill 

Pump – Clinical Perspective 


Drugs – Trial 1 

Thrombin Receptor Antagonists in Prevention of 

Atherothrombotic Ischaemic Events: TIMI 50 

Dr Jaydeep Sarma 

Drugs – Trial 2 

Nesiritide in Acute Decompensated Heart Failure: ASCEND-HF 

Dr Simon Williams 

Drugs – Clinical Perspective 

Dr Colin Forfar 

15.00-16.30 Exchange Hall BCS Session 

61 BCS points of view – working group reports 

Chairs: Prof Simon Ray, Dr Anthony Salmon 

ACHD interventions: working group report 

Dr Paul Clift 

ACHD interventions: implications of report 

Dr Robert Henderson 

Chairs: Dr Nick West, Prof Tom Quinn 

Acute Cardiac Care Units: working group report 

Dr David Walker 

Acute Cardiac Care Units: implications of report 

Dr Scott McLean 


Wednesday 30th May




62 How to session: case-studies 

Chairs: Dr Suzanna Hardman, Jacqui Hunt RN, 

Jennifer Jones MCSP 

Case 1 – An at risk AF patient who ended up in acute care 

with a CVA 

Dr Kathryn Griffith 

Case 2 – Acute care of a PPCI patient re-admitted with 

chest-pain in less than 30 days! 

Jacqui Hunt RN 

Case 3 - A re-admitted patient with a history of risk, acute 

events and now CHF. Should / did this patient now receive 

rehabilitation and with what outcome? 

Annie MacCallum RN 


63 Physiology for Physiologists – Inherited Cardiac 

Conditions 

Chairs: Mr Robert Edwards, Ms Sophie Blackman 

An Overview – Pathophysiology and Genetics of Inherited 

Cardiac Conditions 

Dr Amanda Varnava 

Case Studies – Interesting echos in Inherited Cardiac 

Conditions 

Dr Beth Unsworth 

NICE Guidelines – Implementing NICE Guidance for ICDs 

Mr Mark Squirrell 

ICD Programming – Getting the Programming Right 

Mr Robert Edwards


Wednesday 30th May

Floor Plan and Exhibitors 

The Exhibition will be open the following times: 

Monday 28 May: 10:00 to 17:30 

Tuesday 29 May: 08:00 to 17:30 

Wednesday 30 May: 08:00 to 16:00 

Programme Breaks and activities 

Breaks in the programme for time in the Exhibition are as follows: 

Monday 28 May 

10:00 to 10:30 Tea and coffee 

12:00 to 13:00 Lunch 


Tuesday 29 May 


12:00 to 13:00 Lunch 


Wednesday 30 May 


12:00 to 13:00 Lunch 

14:30 to 15:00 90th Birthday Tea Party 

During the breaks please visit the stands, see the Education in the 

Exhibition in the General Information section of this programme – take 

part in a simulator session, watch the Sports Arena activities, review the 

educational and abstract posters and network with colleagues.

Lunch and breaks 

Lunch bags will be provided free of charge for all. These will 

be available from the Red, White and Blue Lounge areas in the 

Exhibition. Free tea and coffee will also be available from these 

lounge areas during the breaks. The BCS will host a 90th Birthday 

Tea party during the Wednesday afternoon break. 

BCS Organisers’ Contact for the Conference 

The contact telephone number for the Organisers’ Office during the 

conference is 0161 827 7650 ext. 2250. The Organisers’ Office is 

located in the Exhibition Hall, see map on page 56. 

For any information on this year’s Annual Conference and/or the BCS 

Annual Conference 2013 please visit the Organisers’ Office. 


p55 

Floor Plan and Exhibitors


FH 

VE.C 


Exhibition Floor Plan 

BAS/BSCR Stands 

B6 Ultra-Violet Products Ltd (UVP) 

B7 MediaCybernetics 

B8 Melford Laboratories Ltd 

B9 World Precision Instruments (WPI) 

B11 CamNTech 

B12 Moor Instruments 

B13 Hamamatsu Photonics 

B14 VisualSonics 

B15 Olympus 

Charity Stands 

C1 CIRCULATION FOUNDATION 

C2 British Society of Echocardiography 

C3 SADS UK 

C4 Cardiomyopathy Association 

C5 British Society for Heart Failure (BSH) 

C6 GUCH Patients Association 

C8 Education For Health 

FH 

BAS/BSCR 

Posters 

Fitzroy Atrium 

BCS 

Posters 

6.5 

3.00 

3 

Access to 

Conference Baby 

Change 

4 

370 

Wisepress Medical Bookshop 

12 

2 

375 

Archivist 4 

Corner 

8 

378 

Internet 

Station 

sponsored 4 

by 

Roche 

8 

2 

Fitzroy Theatre 

24 

1 

12 

BAS/BSCR 

3 

Lounge 

12 

Servier Laboratories 3 

Ltd 

24 

4 

8 

BAS/BSCR Exhibition Area 

2 3 3 

8 

3 

3 

3 

2 

B6 B15 B14 

B7 

B8 

B9 

6 

6 

6 

6 

3 

322 341 

3 Itamar 

3 

Medical BJCN 

Ltd 9 

9 

2 325 326 

NHS 

2 

Improvement 8 MDDUS 8 

4 

4 

6 

8 

6 

2 

2 

6 6 

6 6 

3 2 

2 

2 

Wesleyan Medical Visit Manchester 

Sickness 6 Information Desk 10 

Safety 

3 First 

Services 

Medis Medical 

Imaging 3 

Systems BV 

Ltd 6 6 

3 

4 

3 

8 

336 

6 

6 

6 

8 

White Lounge 

88 

3 BG Medicine Healthcode 3 

Inc 

Ltd 

12 9 

3 Star 

Randox 3 

Cardiology 

9 9 

234 

4 HeartWare 

4 UK 

Shire Medical 

Pharmaceuticals 

Ltd Ltd 

12 

9 8 

3 3 2 

Red Lounge 

Clinical & Scientific 

Exchange Area 

80 

108 

3 Infinitt UK 

Ltd 12 

4 

144 

11 AstraZeneca 

156 

160 

C1 C2 C3 

180 

C8 

C7 

C6 

14.5 

B11 

B10 

C4 

C5 

260 

B13 

3 

B12 

3 

323 320 

324 

2 

3 

FH 

4 

5 

Charity 

Block 

327 

2 

3 

4 

3 

8 6 

4 2 

14 

3 

VE.B 

12 

11 

10 

212 

FA 

4 

240 246 

232 239 

236 

9 

8 

3 

238 

142 

10 

10 

12 

55 


190 

BCS 

ORGANISERS 

OFFICE 

5 

5 

10 

10 

148 

141 

Simulator Area 

10 


3 3M Health 

Care Ltd 12 

4 

5 

5 

27.5 

27.5 

100 

100 

120 

5.5 

5.5 

3 

134 

3 Sor 

Grou 

128 

3 Vasm 

Techno 

LT 

126 

Ab 

Hea 

5 

Pro 

L 

5 

118 

110 

Glocal 

3Procurem 

Service 

Ltd 

112 

2 ProtecX 

102 

3 Edw 

Lifes 

92 

7 

12 

F 

BCS 

Area 

70 

Sim

141 

3 3M Health 

Care Ltd 12 

4 

5 

5 

lheim 

rea 

rea 

27.5 

27.5 

100 

100 

120 

5.5 

5.5 

118 

110 

20 

Sanofi 

114 

20 

40 

Glocal 

3Procurement 

Services Verathon 

Ltd 6 

5 

® Medical 

2 112 ProtecX Medical Ltd 

8 

20 

4 

4 

4 

4 

102 106 

3 Edwards 

Lifesciences Roche 

12 

5 

Diagnostics 

92 

20 

98 

7 

Cranlea 

5 

BCS Simulator & Co 

Area Reception 

70 

27 

140 

15 

3 


96 

Huntleigh 

14 

7 

3 

5 

134 138 

3 Sorin British Cardiovascular 3 

Industry Association 

Group 

9 15 

128 132 

3 Vasmed 

Technologies 

LTD 9 

NHS National 

Genetics Education 3 

and Development 

Centre 

9 11 

126 130 

Abbott 

British 

Healthcare 

5 

Heart 5 

Products 

Foundation 

Ltd 

5 

12 

FH 

4 

5 

8 

8 

2 

4 

FH 

34 

Blue Lounge 

10 Bayer Healthcare 

10 

6 

6 

50 

60 

8 

8 

8 

BCS 90th 

Birthday 

Lounge 

8 

BCS.COM 

Sports Arena 

VE.A 

3 

88 

80 

80 

48 

48 

Catering Units 

8 

24 

3 

7 

3 ACC 

6 

9 

3 Cardiology 

News 

9 

3 

3 

5Coronary 

3 Heart 

Publishing Ltd 

9 

4 

3 ESC 

9 

3 

3 UEMS 

9 

2 

3 CRY 

9 

3 

BCS 

Executive Room 

Baby 

Change 

WP 

CLOAKS 

EXITS 

Entrance 

Central 

3 

WP 

FA 


FA 

Central 

4 

WP 

FA 

EXITS 

p57


Conference Floor Plan 

REAR CAR PARK 

WATSON STREET 

1 

FITZROY THEATRE 

& ATRIUM 

2 

CHARTER SUITE 

THE GALLERY 

LOWER MOSLEY STREET 

4 

BCS ORGANISERS 

OFFICE 

EXHIBITION HALL 

METROLINK

EXCHANGE 

HALL 

CHARTER FOYER 

SPORTS 

ARENA 

ENTRANCE 

EXCHANGE 

AUDITORIUM 

REGISTRATION 

CENTRAL 

FOYER 

EXCHANGE 

FOYER 

WINDMILL STREET 

MAIN 

ENTRANCE 

CENTRAL 8 

SPEAKER PREVIEW ROOM 

CYCLATHON 

HOSTED BY CRY 


p59

CARRY 

ON IN 

THE CATH 

LAB! 

‘Roger Dart’ has just been admitted direct to the cath 

lab with a heart attack…how will the team respond? 

…will they be a good team? 

A BCS fi lm produced in conjunction with Barts and The London NHS Trust 

Simulation Centre and Cardiovascular Training Institute, illustrating nontechnical 

skills training through simulation. 

Introduced by 

Dr Sarah Clarke for the BCS 

Directed by 

Dr Andrew Wragg, 

Dr Chris Saddler 

Starring 

(in his fi rst fi lm debut) 

Dr Iain Simpson 

With 

A cath lab team 


Auditorium 

Doors open 13.00

Gold standard markers for heart failure 

Elecsys ® NT-proBNP 

Diagnose heart failure 

Obtain the answers required to help rule-in 

or rule-out heart failure.. 

Stratify risk 

Accurately predict morbidity, mortality and 

hospitalisation in patients with heart failure. 

Manage renal patients 

NT-proBNP provides important information 

for the detection, prognosis and monitoring 

of cardiovascular disease in renal patients. 

International approval 

FDA approved and recommended by ESC 

for the diagnosis and assessment of heart 

failure. NT-proBNP is a key performance 

indicator for patients suspected with heart 

failure without previous MI (NICE 2010). 

Roche Diagnostics Limited, Charles Avenue, 

Burgess Hill, West Sussex RH15 9RY 

www.roche.co.uk 

*calls to this number may be recorded 

Elecsys ® cardiac Troponin T high sensitive 

Diagnose AMI on admission 

Superior sensitivity enables earlier 

diagnosis and faster rule-out of acute 

myocardial infarction. 

Enhance prognosis 

Predict cardiovascular mortality in patients 

with stable artery disease, chronic heart 

failure and chronic renal failure. 

Identify risk 

High sensitivity helps to select patients who 

may require further intervention or therapy. 

Meet recommended guidelines 

Improved sensitivity and excellent precision 

meet international recommendations for the 

diagnosis of AMI. 

Find out more Call 01444 256000* for more information.

Roche Elecsys NT-proBNP testing 

improves patient pathway at East Sussex 

Healthcare NHS Trust 

The new heart failure service 

at East Sussex Healthcare NHS 

Trust, part of a new quality 

improvement programme, 

has reduced unnecessary 

admissions, boosted diagnoses 

of heart failure and made 

annual savings for the PCT of 

up to £270,000. 

Better Patient 

Outcomes 

The Clinical Biochemistry 

Laboratory at Eastbourne 

District General Hospital 

offers Roche Elecsys NTproBNP 

testing as a routine 

service to GPs throughout 

the area. NT-proBNP test 

requests are made when the 

GP identifies a patient with 

suspected heart failure. 

The Roche Elecsys NTproBNP 

assay is used 

on a Roche Modular 

E170 immunoassay 

platform. With a 24 

hour turnaround time, 

the samples are tested 

on the same day that 

they are received and 

results are sent out to 

the GPs electronically 

that evening. 

The results tell the GP 

if, and how quickly, the 

patient should be referred 

for specialist opinion and 

further investigation by echo 

cardiogram (ECG), following 

NICE guidelines1 and 

additional age/sex related 

criteria. Criteria for selection 

and oversight are provided 

by a specialist GP, Dr Richard 

Blakey, employed by the 

Trust. If NT-proBNP levels 

are high, patients are referred 

quickly. This speeds up 

the patient pathway, where 

delays can be costly in terms 

of patient outcomes. 

The laboratory provides 

testing reports (where the 

test requests are coming 

from; patient profiles; results, 

etc) so that the primary care 

commissioners can check 

compliance of both patients 

and GPs. This ensures that 

the right patients are tested 

and the right follow-up is 

provided. Oversight and 

feedback is provided by the 

GP specialist, which is vital 

to ensure and maintain 

appropriate testing. 

Cost Savings 

Funding for NT-proBNP 

testing is provided by the 

Local PCT. Savings are made 

in the improvement of the 

patient pathway. Testing for 

NT-proBNP has reduced the 

number of patients requiring 

referral for specialist 

assessment and ECG. 

A recent audit of the 

service has shown that 

NT-proBNP testing 

has spared nearly 700 

patients from being 

referred in the last year. 

This alone has resulted 

in annual savings of up 

to £270,000 against the 

annual QIPP savings 

target for cardiology of 

£700,000 2 . 

The testing service provided 

by the laboratory is seen as 

an integral part of the patient 

process and contributes greatly 

to the perceived value of 

pathology within the Trust. 

Find out more 

Contact your local Roche 

representative or the Roche 

HIVD Centralised Diagnostics 

Team on 01444 256000. 

References 

1. NICE clinical guideline 108 (2010). Chronic 

heart failure: Management of chronic heart 

failure in adults in primary and secondary 

care. 

2. Dr Richard Blakey (2012) How our BNP 

testing service saved £270,000 in a year. Pulse, 

22 February 2012.

Inflammation and 

Atherosclerosis 

VENUE & DATE: 

Munich, Germany 

September 20-21, 2012 

ORGANIZERS: 

Christian Weber 

and Abcam 

INVITED SPEAKERS: 

• Christoph Binder 

• Myron Cybulsky 

• Stefanie Dimmeler 

• Ebru Erbay 

• Frederic Geissmann 

• Beat Imhof 

• Eicke Latz 

• Francois Mach 

• Ziad Mallat 

• Stephane Potteaux 

• Daniel Rader 

• Katey Rayner 

• Alan Tall 

Discover more at abcam.com/munich 

191_12_AH

Get active in 

metabolism 

research 

A comprehensive range of 

tools for metabolism 

and mitochondrial 

research. 

Try a new approach in your research using our wide 

range of tools. From activity assays, In-cell ELISA, 

dipstick assays to highly validated antibodies with 

diverse species cross reactivity. Allow your metabolism 

research to go further. 

Discover more at abcam.com/getactive 

191_12_AH

Exhibitors Guide 

Exhibitors index – Company and Stand 

Organisation Stand Page 

Name Number Number 

3M Health Care Ltd .................................................... 141 ............68 

Abbott Healthcare Products Limited ........................... 126 ............68 

AstraZeneca .............................................................. 144 ............68 

Bayer Healthcare .......................................................... 34 ............68 

BG Medicine, Inc. ....................................................... 240 ............69 

The British Journal of Cardiac Nursing ....................... 327 ............69 

Boehringer Ingelheim.................................................. 160 ............69 

British Cardiovascular Industry Association ................ 138 ............70 

British Heart Foundation ............................................. 130 ............70 

British Society for Heart Failure (BSH) ...........................C5 ............70 

British Society of Echocardiography .............................C2 ............70 

Cardiac Risk in the Young CRY ...................................... 2 ............71 

Cardiology News ............................................................ 6 ............71 

Cardiomyopathy Association ........................................C4 ............71 

Circulation Foundation .................................................C1 ............72 

Coronary Heart Publishing Ltd........................................ 5 ............72 

Education for Health ....................................................C8 ............72 

Edwards Lifesciences ................................................. 102 ............72 

European Society of Cardiology ..................................... 4 ............73 

GUCH Patients Association ..........................................C6 ............73 

Healthcode Ltd .......................................................... 246 ............73 

HeartWare .................................................................. 234 ............73 

Huntleigh .................................................................... 140 ............74 

Infinitt UK Ltd ............................................................. 142 ............74

Organisation Stand Page 

Name Number Number 

Itamar Medical Ltd ..................................................... 324 ............74 

MDDUS ..................................................................... 326 ............74 

Medis medical imaging systems bv ............................ 320 ............75 

NHS Improvement ..................................................... 325 ............75 

NHS National Genetics Education 

and Development Centre ........................................... 132 ............75 

ProtecX Medical Ltd ................................................... 112 ............76 

Randox Cardiology ..................................................... 239 ............76 

Roche Diagnostics ..................................................... 106 ............76 

SADS UK .....................................................................C3 ............76 

Safety First Sales Ltd.................................................. 323 ............77 

Sanofi......................................................................... 118 ............77 

Servier Laboratories Ltd ............................................. 260 ............77 

Shire Pharmaceuticals Ltd .......................................... 236 ............77 

Sorin Group ............................................................... 134 ............78 

Star ............................................................................ 232 ............78 

UEMS Cardiology Section .............................................. 3 ............78 

UK Medical Ltd .......................................................... 238 ............78 

Vasmed Technologies LTD ......................................... 128 ............79 

Verathon ® Medical ................................................... 114 ............79 

Wesleyan Medical Sickness ....................................... 322 ............79 

Wisepress Medical Bookshop .................................... 370 ............79 


p67


Exhibitors Listing 

3M Health Care Ltd Stand no. 141 

Phone: +44 (0)1509 613410 

Email: littmann.uk@mmm.com 

Website: www.littmann.co.uk 

3M Littmann® Stethoscopes are delighted to announce the arrival of 

the new Lightweight II SE Nursing Stethoscope. This general-purpose 

stethoscope is an excellent, affordable choice for blood-pressure and 

patient assessment. Littmann quality is apparent from the soft-sealing 

eartips to the combination bell/diaphragm chestpiece. Visit our stand 

for more information. 

Abbott Healthcare Products Limited Stand no. 126 

Phone: +44 02380 467000 

Email: Pamela.todd@abbott.com 

Website: www.abbott.co.uk 

Abbott Healthcare Products Ltd markets treatments in cardiovascular 

disease for secondary prevention post myocardial infarction, lipid 

regulation and hypertension to benefit patient care. Abbott Healthcare 

Products Ltd is part of Established Pharmaceuticals Division within 

Abbott and commits to increased patient care through sharing 

knowledge with healthcare providers and patients. 

AstraZeneca Stand no. 144 

Website: www.astrazeneca.com 

AstraZeneca is a global, innovation-driven biopharmaceutical business 

focused on the discovery, development and commercialisation of 

prescription medicines. AstraZeneca is committed to nurturing a culture 

of innovation to: 

> focus on unmet need in serious disease areas 

> build industry-leading capabilities to take advantage of new science 

> collaborate externally to broaden our innovation base 

Bayer Healthcare Stand no. 34 

Phone: 07831 596944 

Email: ned.kelly@bayer.co.uk

Bayer Healthcare have recently introduced an oral anticoagulant 

with a variety of indications in the area of thromboembolic disease. 

During the BCS Annual Conference, Bayer will be hosting a number 

of Meet the Expert sessions on the exhibition stand where various 

aspects of anticoagulation will be discussed. 

BG Medicine, Inc. Stand no. 240 

Phone: +1 (781) 890-1199 

Email: communications@bg-medicine.com 

Website: www.bg-medicine.com; www.galectin-3.com 

BG Medicine is a life sciences company focused on the discovery, 

development, and commercialisation of novel, biomarker-based 

diagnostics to improve patient outcomes and contain healthcare costs. 

The Company recently launched the BGM Galectin-3TM test for use in 

patients with heart failure. For additional information about galectin-3 

testing, please visit www.galectin-3.com. 

The British Journal of Cardiac Nursing Stand no. 327 

Phone: +44 (0) 207 738 5454 

Email: chloe.moffat@markallengroup.com 

Website: www.cardiac-nursing.co.uk 

The British Journal of Cardiac Nursing is a monthly clinical and 

professional review journal. It aims to provide the highest standards of 

clinical reviews and reflects the latest developments in cardiovascular 

care. All specialties of cardiology are represented, whether in acute 

trusts or in the community specialist team. 

Boehringer Ingelheim Stand no. 160 

Phone: +44 (0) 1344 424600 

Website: www.boehringer-ingelheim.co.uk 

The Boehringer Ingelheim group is one of the world’s 20 leading 

pharmaceutical companies. Headquartered in Germany, it operates 

globally with over 42,000 employees. Since its foundation in 1885, 

the family-owned company has been committed to researching, 

developing, manufacturing and marketing high therapeutic value novel 

products for human and veterinary medicine. 


p69



British Cardiovascular Industry Association Stand no. 138 

Phone: + 44 (0) 20 8980 0679 

Email: bcia@bcos.demon.co.uk 

Website: bcia.uk.com 

BCIA began in May 1997, with membership available to all UK 

manufacturers and suppliers working within the cardiovascular field. 

BCIA’s strategic intent is to help support BCIS in delivering high 

quality education and training, with their flagship meeting, Advanced 

Cardiovascular Intervention, at the forefront. Please contact us for 

membership details. 

British Heart Foundation Stand no. 130 

Phone: +44 (0) 20 7554 0434 

Email: research@bhf.org.uk 

Website: www.bhf.org.uk 

Visit our stand to find out how you can support our Mending Broken 

Hearts Appeal and meet BHF representatives who will be available 

during session breaks to provide advice on: 

> BHF funding schemes 

> Grant writing 

> Our online grants application process 

> Presenting your research to the media 

British Society for Heart Failure (BSH) Stand no. C5 

Phone: +44 (0) 1865 391836 

Email: info@bsh.org.uk 

Website: www.bsh.org.uk 

The BSH is a multi-disciplinary society for healthcare professionals 

involved in the diagnosis and management of heart failure. This year’s 

two-day BSH Autumn Meeting will be held on 29-30 November 2012 in 

London. The next BSH training meetings (medical and nurse) will be on 

7 and 8 February 2013. 

British Society of Echocardiography Stand no. C2 

Phone: +44 (0) 20 7345 5185 

Email: admin@bsecho.org 

Website: www.bsecho.org

Visit the BSE stand for information on membership, accreditation, 

educational courses, apps and more. Accredited members can 

collect their points certificate here. 

The BSE team looks forward to welcoming you; come and say Hi! 

Cardiac Risk in the Young CRY Stand no. 2 

Phone: 01737 363 222 

Email: cry@c-r-y.org.uk 

Website: www.c-r-y.org.uk 

CRY supports those people diagnosed with cardiac conditions and 

offers bereavement support to families affected by YSCD. CRY funds 

fast track services at the CRY Centre for Inherited Cardiovascular 

Conditions and Sports Cardiology, and the CRY Centre for Cardiac 

Pathology. CRY operates a national screening programme and funds 

medical research. 

Cardiology News Stand no. 6 

Phone: +44 (0)131 478 8403 

Email: stuart@pinpoint-scotland.com 

Website: www.cardiologynews.uk.com 

Cardiology News is a unique, highly regarded publication providing an 

invaluable forum for the communication of news and information from 

every aspect of cardiology. Aimed at cardiologists, cardiac surgeons, 

physiologists, cardiac nurses and GPs, each issue features commercially 

unbiased articles from renowned experts, case reports, journal reviews, 

conference round-ups, an events diary and industry updates. 

Cardiomyopathy Association Stand no. C4 

Phone: +44 (0) 1494 791224 

Email: info@cardiomyopathy.org 

Website: www.cardiomyopathy.org 

The Cardiomyopathy Association is there to help affected by 

cardiomyopathy. We work to help them to understand cardiomyopathy, 

allaying their fears and promoting independence. We understand 

and we sympathise but mostly we take action to help. We also 

provide free medical education opportunities for doctors through 

our conference programme. 


p71



Circulation Foundation Stand no. C1 

Phone: +44 (0) 207 973 0306 

Email: Neelam@vascularsociety.org.uk 

Website: www.circulationfoundation.org.uk 

The Circulation Foundation is the UK’s only dedicated vascular disease 

charity. It funds and promotes research into the causes, treatment and 

prevention of vascular disease, and raises awareness of the importance 

of vascular health. The Foundation is the fundraising arm of The Vascular 

Society, the membership organisation for vascular professionals. 

Coronary Heart Publishing Ltd Stand no. 5 

Phone: +44 (0) 845 299 6220 

Email: tim@coronaryheart.com 

Website: www.cardiologyhd.com 

CardiologyHD is a dedicated website community and magazine for 

cardiology professionals. First launched six years ago we have grown to 

become a favourite means for industry communication, and keeping our 

audience updated with the latest advances to their practice. Magazine 

distribution = 2800 copies. Website visitors = 5000 per month. 

Education for Health Stand no. C8 

Education for Health is an education and research charity focusing 

on the education of healthcare professionals as a means of improving 

patient health. We deliver courses nationally and globally, keeping 

students at the forefront of clinical developments and our agenda 

setting research ensures we understand the needs of patients and the 

primary care community. 

Edwards Lifesciences Stand no.102 

Phone: 0870 6062040 

Email: uk_customerservice@edwards.com 

Website: www.edwards.com 

Edwards Lifesciences is the global leader in the science of heart valves 

and hemodynamic monitoring. Driven by a passion to help patients, the 

company partners with clinicians to develop innovative technologies in 

the areas of structural heart disease and critical care monitoring that 

enable them to save and enhance lives.

European Society of Cardiology Stand no. 4 

Phone: +33 492 94 76 00 

Email: communications@escardio.org 

Website: www.escardio.org 

The European Society of Cardiology (ESC) represents more than 

75,000 cardiology professionals from across Europe and the 

Mediterranean. Its mission is “To reduce the burden of cardiovascular 

disease in Europe”. The ESC achieves this through scientific and 

educational activities and the ESC Congress, the largest medical meeting 

in Europe, held this year from 25-29 August 2012 in Munich, Germany. 

GUCH Patients Association Stand no. C6 

Phone: +44 (0) 1473 252007 

Email: admin@guch.org.uk 

Website: www.guch.org.uk 

GUCH Patients Association was established 18 years ago, when 

Professor Jane Somerville realised that patients were not receiving the 

support that they needed. The organisation provides online and offline 

help and information, and works in partnership with the NHS and other 

charities including BHF and the Children’s Heart Federation. 

Healthcode Ltd Stand no. 246 

Phone: +44 (0)1784 263 150 

Email: custserv@healthcode.co.uk 

Website: www.healthcode.co.uk 

Healthcode provides secure online systems to the private health 

market. With an established secure network Healthcode has designed 

a number of tools to help private practices manage a busy practice 

more efficiently. Services include electronic medical billing, practice 

management, clinical coding as well as secure messaging. 

HeartWare Stand no. 234 

Website: www.heartwareinc.com 

HeartWare, Inc. is developing implantable mechanical circulatory 

support systems for treatment of advanced heart failure. HeartWare’s 

lead device, the HeartWare® Ventricular Assist System, incorporates 

state-of-the-art peripherals and features the only full-output pump 

designed to be implanted less invasively in the pericardial space. The 

HeartWare® System is commercially available in Europe. 


p73



Huntleigh Stand no. 140 

Phone: +44 (0) 29 2048 5885 

Email: sales@huntleigh-diagnostics.co.uk 

Website: www.huntleigh-diagnostics.com 

NEW in Vascular Assessment – the Diagnostics product division 

of Huntleigh are displaying its Dopplex ABIlity, which automatically 

measures the ABPI in less than 5 minutes. In conjunction with this 

will be Huntleigh world renowned Dopplex handheld Doppler range, 

offering even greater performance, quality and reliability. Visit Stand 140 

for demonstrations. 

Infinitt UK Ltd Stand no. 142 

Phone: +44 (0) 1344 312100 

Email: kscho@infinitt.com 

Website: www.infinitt.com 

INFINITT Cardiology PACS is a web-based suite of image visualisation, 

clinical and reporting tools for Cardiology, Cardiovascular and Vascular 

Imaging, EKG, and Nuclear Medicine. Can be used as a standalone 

system, or fully integrated with Radiology PACS/Enterprise Database, 

consolidating data for the HIS. 

Itamar Medical Ltd Stand no. 324 

Phone: +972-4 6177 000 

Email: info@itamar-medical.com 

Website: www.itamar-medical.com 

The patented Peripheral Arterial Tone (PAT®) signal - the noninvasive 

“window” to both the cardiovascular and autonomic nervous systems. 

EndoPAT: the only noninvasive, FDA-cleared device diagnosing 

endothelial dysfunction – the early indicator of arterial health. This 

15-minute, office-based diagnostic is used by Mayo Clinic, Framingham 

Heart Study & others. 

MDDUS Stand no. 326 

Phone: 0845 270 2038 

Email: jmcaulay@mddus.com 

Website: www.mddus.com

The MDDUS is a mutual organisation that has been providing 

indemnity, advice and guidance on medico-legal matters to 

members who encounter professional difficulties for over 100 

years. With a team of highly qualified and experienced personnel, 

and offices in Glasgow and London, the MDDUS offers a quality, 

personalised service at competitive rates. Visit our stand for a 

personalised quote. 

Medis medical imaging systems bv Stand no. 320 

Phone: +31 (0)71 522 32 44 

Email: sales@medis.nl 

Website: www.medis.nl 

Medis is a leading provider of software that enables accurate 

quantification of cardiovascular images. Medis’ solutions for the 

imaging modalities MRI, X-ray angiography, IVUS and OCT help 

medical professionals to generate crucial image based evidence, also 

for clinical research purposes, to improve the quality of diagnosis and 

patient follow-up. 

NHS Improvement Stand no. 325 

Website: www.improvement.nhs.uk 

NHS Improvement and its predecessors the Heart Improvement 

Programme and Coronory Heart Disease Collaborative, has led the field 

in improving NHS cardiac services since 2000. Working closely with 

the Department of Health and Cardiac Networks we provide a national 

resource for quality service improvement. 

NHS National Genetics Education 

and Development Centre Stand no. 132 

Phone: +44 (0) 121 623 6977 

Email: silvana.ioannou@geneticseducation.nhs.uk 

Website: www.geneticseducation.nhs.uk 

The NHS National Genetics Education and Development Centre 

has developed and supported the learning and teaching of genetics 

concepts, including learning outcomes in genetics and genomics 

for healthcare groups and support their adoption into curricula and 

devised a framework of genetics activities in clinical practice. 


p75



ProtecX Medical Ltd Stand no. 112 

Phone: +44 (0)1462 440715 

Email: enquiries@protecx.co.uk 

Website: www.protecx.co.uk 

ProtecX Medical Ltd are leading manufacturers of quality Radiation 

Protection products, from lead & Starlite lead-free aprons to protective 

accessories including leaded eyewear, radiation reducing gloves and 

shielding. ProtecX will be exhibiting their latest colours and stylish prints 

We look forward to welcoming to our stand. 

Randox Cardiology Stand no. 239 

Phone: +44 (0)28 94422413 

Email: marketing @randox.com 

Website: www.randox.com 

Randox are an international clinical diagnostics company based in 

Northern Ireland, with a presence in over 150 countries worldwide. 

Randox have recently launched a new assay for the biomarker of 

myocardial ischemia H-FABP, which is an additive marker to both 

conventional and hsTroponins in the acute assessment & triage of 

patients with chest pain. 

Roche Diagnostics Stand no. 106 

Phone: +44 (0) 1444 256000 

Email: burgesshill.coaguchek@roche.com 

Website: www.coaguchek.co.uk 

To view our market leading Point of Care portfolio in the fields of 

coagulation and cardiovascular risk management, in particular 

our cobas h232 awarded level 3 by iTAPP work programme and 

CoaguChek patient self-care meters, please visit stand 106. 

SADS UK Stand no. C3 

Phone: +44 (0) 1277 811215 

Email: info@sadsuk.org 

Website: www.sadsuk.org 

The cardiac charity SADS UK works in the community to save lives 

and support people affected by SADS (Sudden Arrhythmic Death 

Syndrome). The SADS UK Big Shock Campaign urges Government to 

make defibrillators mandatory in schools. SADS UK continues to work 

with schools to put defibrillators and training in place.

Safety First Sales Ltd Stand no. 323 

Phone: +44 (0) 2890 352920 

Email: simon@safetyfirstsales.com 

Website: www.safetyfirstsales.com 

We take our responsibility for manufacturing Personal Protection 

Equipment seriously. Our customers expect items of PPE to achieve 

the highest level of protection possible. To ensure these expectations 

are met, our products are manufactured from the highest quality 

materials available and are constructed by a quality conscious 

manufacturing team. 

Sanofi Stand no. 118 

Email: james.compton-dando@sanofi-aventis.com 

Website: www.sanofi.co.uk 

In the UK, Sanofi, an affiliate of the global pharmaceutical company 

Sanofi, is a dynamic organisation working to meet the needs of 

healthcare professionals and their patients. Our portfolio of products 

and services closely match the priorities of the NHS and include 

diabetes, cardiovascular disease, thrombosis, oncology and vaccines. 

Based in Paris, Sanofi operates in over 100 countries. 

Servier Laboratories Ltd Stand no. 260 

Phone: +44 (0) 1752 662744 

Website: www.servier.co.uk 

Servier Laboratories is the UK subsidiary of The Servier Research 

Group, the leading independent French research based pharmaceutical 

company. The key franchises of the Servier Research Group are 

cardiovascular disease, diabetes, rheumatology, Central Nervous 

System and oncology. For further information visit www.servier.co.uk 

Shire Pharmaceuticals Ltd Stand no. 236 

Phone: +44 (0) 1256 894803 

Email: idavidson@shire.com 

Website: www.shire.com 

Shire Human Genetic Therapies work closely with specialist 

physicians, nurses and other healthcare professionals to develop 

and market medicines that aim to improve quality of life for patients, 

their families and carers. We currently provide enzyme replacement 

therapies for the treatment of Fabry disease, Gaucher disease and 

Hunter Syndrome. 


p77



Sorin Group Stand no. 134 

Phone: +44 (0) 1452 638500 

Email: salesuk@sorin.com 

Website: www.sorin-crm.com 

Sorin Group is a global medical device company and leader in the 

treatment of cardiovascular diseases. The Company develops and 

manufactures medical technologies for cardiac surgery and the treatment 

of cardiac rhythm disorders. Each year, over one million patients are 

treated with Sorin Group devices in more than 80 countries. 

Star Stand no. 232 

Phone: +44 (0) 1628 581240 

Email: solutions@starmedical.co.uk 

Website: www.starmedical.co.uk 

Star’s a full-service resourcing house that brings the best people 

and opportunities together in healthcare, on a direct to headcount, 

contract and Master Vendor basis. Whether you’re looking for a job, or 

recruiting, we’d love to help; visit us on stand 232. 

UEMS Cardiology Section Stand no. 3 

Email: GriebenowR@kliniken-koeln.de 

Website: http://www.uems-cardio.org/ 

UEMS Cardiology Section is one of the 38 specialty sections of UEMS 

which aims to harmonize training and education in medicine in Europe. 

Cardiology Section has started the European Cardiology Section 

Foundation (ECSF) as a legal backbone for EBAC, which is responsible 

for the accreditation of international CME. 

UK Medical Ltd Stand no. 238 

Phone: +44 (0) 114 268 8880 

Email: cardiac@ukmedical.com 

Website: www.ukmedical.com 

UK Medical specialises in the supply of premium quality, single-use 

interventional medical devices. Our Cardiac range includes the unique 

SuperKetch haemostatic valve for angioplasty, StemiCath thrombus 

aspiration catheter, King of Hearts Express® AF and dedicated 

Gems ECG interpretation and management software options. We 

look forward to meeting you.

Vasmed Technologies LTD Stand no. 128 

Phone: 07909224866 

Email: Richard.f@steripharm.co.uk 

Website: www.vasmedtech.com 

A Dubai based manufacturer of CE Marked PTCA/PTA catheters and 

stents since 2002. Vasmed Technologies have emerged as a leading 

manufacturer of cardio-vascular devices. Our custom-built clean 

rooms are equipped with state-of-the-art manufacturing equipment, 

guaranteeing reliable and affordable quality products. 

Verathon ® Medical Stand no. 114 

Phone: +44 (0) 1494 682 650 ext 5005 

Email: salesuk@verathon.co.uk 

Website: www.verathon.co.uk 

Verathon ® brings the new Heartscape 3D ECG System, with 80-lead 

vest. Heartscape is designed to give cardiologists a more complete 

diagnostic picture by providing a 360° view of the heart. Featuring an 

easy-to-apply vest, touch screen colour monitor, rotating 3D colourgraphic 

and diagnostic algorithm to help accelerate diagnosis. 

Wesleyan Medical Sickness Stand no. 322 

Phone: 0808 100 1884 

Email: financialreview@wesleyan.co.uk 

Website: www.wesleyan.co.uk 

Wesleyan Medical Sickness provides specialist financial advice based 

on an in-depth understanding of the medical profession. We work 

closely with clients to develop bespoke, long-term financial plans 

that meet their needs, through each stage of their career and into 

retirement. To see how we can help you plan for a profitable future, 

call 0808 100 1884. 

Wisepress Medical Bookshop Stand no. 370 

Phone: +44 (0) 208 715 1812 

Email: bookshop@wisepress.com 

Website: www.wisepress.com 

Wisepress.com, Europe’s leading conference bookseller, has a 

complete range of relevant books and journals which can be purchased 

at the stand or, if you would rather not carry them, posted to you – 

Wisepress will deliver worldwide. We also have a comprehensive 

medical and scientific online bookshop with great offers. 


p79

Abstracts and Posters 

Abstract / Poster Guide 

This year 350 abstracts were submitted under 10 categories. Five were 

submitted for the Young Research Workers Prize. The abstracts were marked 

by independent experts and the YRWP submissions were marked by the 

Academic & Research Committee. 

The top 40% scoring abstracts in each category were accepted and 8 poster 

sessions developed for the conference. The abstracts of the day are on display 

at the back of the Exhibition, in the Fitzroy Atrium. The BAS/BSCR posters are 

also in a dedicated section of the Fitzroy Atrium. 

The abstracts will be presented to expert discussants in the Fitzroy Atrium 

during the last 30 minutes of certain sessions in the Clinical Science / 

Translational Research Track and the Imaging Track. See below and 

Programme at a Glance for further information. The abstract category and 

abstract numbers to be discussed are as follows: 

Track / Date Session time Discussant Category / No. 

start time 

Clinical Science / Translational Research Track 

Monday 28 May 10:30 to 12:00 11:30 Heart Failure (1-18) 

15:00 to 16:30 16:00 Interventional Cardiology 

(19-48) 

Tuesday 29 May 08:30 to 10:00 09:30 Cardiac Rhythm 

Management (49-67) 

13:00 to 14:30 14:00 Valve / pericardial 

cardiomyopathy (68-80) 

Wednesday 30 May 08:30 to 10:00 09:30 Basic Science (104-121) 

10:00 to 12:00 11:30 Acute Coronary 

Syndromes (122-134) 

13:00 to 14:30 14:00 Stable IHD / prevention 

HT / lipids (135-151) 

Imaging Track 

Wednesday 30 May 08:30 to 10:00 09:30 Imaging (81-103)

Young Research Workers Prize 

Five abstracts (A to E) have been selected for the final of the YRWP 

which will take place on Tuesday 29 May in the Fitzroy Theatre at 10:00. 

Please see session number 27 in the main programme for further details. 

BAS/BSCR Abstracts 

The BAS/BSCR abstracts will be displayed in a dedicated area in the Fitzroy 

Atrium and will be presented as follows: 

Monday 29 May 15:00 to 16:30 BAS/BSCR 


p81 

Abstracts and Posters



Abstract / Poster Listing – Title and Lead Author 

Young Research Workers’ Prize 

A GENE-BASED RESTORATION OF AKT ACTIVITY IN 

ENDOTHELIAL PROGENITOR CELLS FROM HUMAN SUBJECTS 

AT HIGH CARDIOVASCULAR RISK RESCUES VASCULAR 

REPARATIVE CAPACITY 

Cubbon, RM 

The University of Leeds 

B ASSESSMENT OF VALVULAR CALCIFICATION AND 

INFLAMMATION BY POSITRON EMISSION TOMOGRAPHY 

Dweck, MR 

University of Edinburgh 

C ENDOTHELIAL SPECIFIC NOX2 OVER-EXPRESSION 

INCREASES SUSCEPTIBILITY TO ANGIOTENSIN II INDUCED 

AORTIC DISSECTION 

Fan, L 

Oxford University 

D ENDOTHELIUM SPECIFIC INSULIN RESISTANCE LEADS TO 

ACCELERATED ATHEROSCLEROSIS: A ROLE FOR REACTIVE 

OXYGEN SPECIES 

Gage, MC 

Leeds University 

E RIGHT VENTRICULAR ORIGIN OF ARRHYTHMIAS IN SCN5A+/- 

MICE IS DUE TO REDUCED NA+ AND HIGHER K+ CHANNEL 

EXPRESSION AND FUNCTION 

Martin, CA 

University of Cambridge


001 UNBIASED ASSESSMENT OF SYMPTOMATIC 

“RESPONSE RATE” TO CARDIAC RESYNCHRONIZATION 

THERAPY BY SYSTEMATIC REVIEW OF RANDOMISED 

CONTROLLED TRIALS (REVERSE, MIRACLE, MIRACLE ICD, 

MIRACLE ICDII, CARE-HF, COMPANION, CONTAK-CD, AND 

MUSTIC) 

Sohaib, S M A 

Imperial College London 

002 A RANDOMISED STUDY OF TEMPORARY EPICARDIAL CARDIAC 

RESYNCHRONISATION VERSUS CONVENTIONAL RIGHT 

VENTRICULAR PACING IN CARDIAC SURGICAL PATIENTS. 

Russell, SJ 

Wales Heart Research Institute, University Hospital of Wales 

003 VALIDATING MARKERS OF MECHANICAL DYSSYNCHRONY 

BY EXPERIMENTAL MANIPULATION OF INTERVENTRICULAR 

TIMINGS: WHAT IS NEEDED TO MAKE THEM A REASONABLE 

PROSPECT FOR CARDIAC RESYNCHRONISATION THERAPY 

SELECTION? 

Pabari, PA 

International Centre for Circulatory Health, Imperial College 

004 SIMULTANEOUS INVASIVE PRESSURE AND FLOW 

MEASUREMENTS DURING AV DELAY IMPROVEMENT 

REVEAL A COMPENSATORY PERIPHERAL VASODILATOR 

RESPONSE WHICH ATTENUATES THE INITIAL BLOOD 

PRESSURE INCREMENT: IMPLICATIONS FOR THE DESIGN OF 

OPTIMISATION PROTOCOLS. 

Pabari, PA 


005 CARDIAC MAGNETIC RESONANCE IMAGING: 

UNDERSTANDING MYOCARDIAL MOTION TO PREDICT 

REMODELLING PRE CARDIAC RESYNCHRONISATION 

THERAPY 

Duckett, SG 

Kings College London 



006 IMPROVEMENT IN CORONARY BLOOD FLOW WITH ACUTE 

BIVENTRICULAR PACING IS PREDOMINANTLY DUE TO 

AN INCREASE IN A DIASTOLIC BACKWARD-TRAVELLING 

DECOMPRESSION (SUCTION) WAVE 

Kyriacou, A 

NHLI, St Mary’s Hospital 

007 SHOULD CURRENT MODALITIES OF VV OPTIMISATION BE 

TRUSTED? AN ASSESSMENT OF THE INTENAL VALIDITY OF 

ECHOCARDIOGRAPHIC, ELECTROCARDIOGRAPHIC AND 

HAEMODYNAMIC MODALITIES OF OPTIMISATION 

Kyriacou, A 

St Mary’s Hospital 

008 LEFT VENTRICULAR HYPERTROPHY IS ASSOCIATED WITH 

INTRAMURAL DYSSYNCHRONY ON EXERCISE IN PATIENTS 

WITH HEART FAILURE AND NORMAL EJECTION FRACTION 

Tan, YT 

University of Birmingham 

009 UNCOVERING THE MECHANISM OF THE PARADOXICAL 

ASSOCIATION BETWEEN CARDIAC DYSSYNCHRONY AND 

BETTER SURVIVAL IN HEART FAILURE 

Jabbour, RJ 

Imperial College Healthcare Trust 

010 MULTICENTRE VALIDATION OF THE ADVERSE PROGNOSTIC 

IMPLICATIONS OF DECLINING SERUM ALBUMIN LEVELS IN 

CHRONIC HEART FAILURE 

Jabbour, RJ 

Imperial College Healthcare Trust 

011 HBA1C AND MORTALITY IN DIABETIC INDIVIDUALS WITH 

HEART FAILURE – AN OBSERVATIONAL COHORT STUDY 

Elder, DHJ 

Univeristy of Dundee 

012 AUTOMATED DATA CAPTURE FROM ECHOCARDIOGRAPHY 

REPORTS TO ENHANCE HEART FAILURE POPULATION 

RESEARCH 

Elder, DHJ 

University of Dundee

013 AUDIT OF TERTIARY HEART FAILURE OUTPATIENT 

SERVICE TO ASSESS COMPLIANCE WITH UPDATED 

NICE GUIDELINES 

Pryse-Hawkins, H 

Royal Brompton & Harefield NHS Trust 

014 SPECIALIST INTERVENTION LEADS TO IMPROVED IN- 

PATIENT OUTCOMES IN PATIENTS WITH DECOMPENSATED 

HEART FAILURE: IMPACT OF INTRODUCING A HEART 

FAILURE TEAM 

Masters, J 

University Hospital Southampton 

015 CAN WE PREDICT LIVER FIBROSIS PREOPERATIVE IN 

PATIENTS WHO UNDERGO HEART FAILURE SURGERY AND 

DOES IT INFLUENCE POSTOPERATIVE LIVER FUNCTION? 

Farre, N 

Harefield Hospital 

016 YOUNG PATIENTS WITH HEART FAILURE OFTEN DO NOT HAVE 

MAJOR ECG ABNORMALITIES 

Mahmood, A 

University of Glasgow 

017 MICROVOLT T-WAVE ALTERNANS (MTWA) TESTING IN ‘REAL 

WORLD’ HEART FAILURE (HF): A STUDY OF PREVALENCE AND 

INCREMENTAL PROGNOSTIC VALUE 

Jackson, CE 

BHF Glasgow Cardiovascular Research Centre, University of Glasgow 

018 THE BREAST CANCER, EARLY DISEASE: TOXICITY FROM 

THERAPY WITH EPIRUBICIN REGIMENS ¨C CARDIAC 

ASSESSMENT AND RISK EVALUATION (BETTER-CARE), 

CARDIOVASCULAR MAGNETIC RESONANCE (CMR) SUB- 

STUDY: CYCLE 1 CHANGES PREDICT LATE ANTHRACYCLINE 

CARDIOTOXICITY 

Smith, GC 

Royal Brompton Hospital 



019 DEVELOPMENT AND VALIDATION OF A NOVEL PRESSURE- 

ONLY INTRA-CORONARY INDEX OF CORONARY STENOSIS 

SEVERITY 

Sen, S 


020 COMPARISON OF FFR MEASUREMENTS OBTAINED USING 

CENTRAL VERSUS DISTAL PERIPHERAL INTRAVENOUS 

ADENOSINE INFUSION TO INDUCE HYPERAEMIA 

Sirker, A 

King’s College Hospital 

021 COMPUTER MODELLED CORONARY PHYSIOLOGY AND 

‘VIRTUAL’ FRACTIONAL FLOW RESERVE FROM ROTATIONAL 

ANGIOGRAPHY 

Morris, PD 

Dept Cardiovascular Science, University of Sheffield & Dept 

Cardiology, Northern General Hospital 

022 DYNAMIC THREE-DIMENSIONAL WHOLE HEART MAGNETIC 

RESONANCE MYOCARDIAL PERFUSION IMAGING: VALIDATION 

AGAINST PRESSURE WIRE DERIVED FRACTIONAL FLOW 

RESERVE FOR THE DETECTION OF FLOW-LIMITING 

CORONARY HEART DISEASE 

Jogiya, R 

King’s College London 

023 AN EX-VIVO ‘WHOLE HUMAN HEART MODEL’ FOR THE 

DEVELOPMENT OF INTRAVASCULAR IMAGING 

Johnson, TW 

Bristol Heart Institute 

024 VALIDATION OF TISSUE CHARACTERISATION AND VULNERABLE 

PLAQUE CLASSIFICATION USING VIRTUAL HISTOLOGY IVUS 

(VH-IVUS) AGAINST HUMAN POST-MORTEM HISTOLOGY 

Obaid, DR 


025 FEASIBILITY OF COMBINED CARDIOVASCULAR 

MAGNETIC RESONANCE IMAGING AND 

PERCUTANEOUS CORONARY INTERVENTION IN A 

HYBRID LABORATORY 

Morton, G 


026 LEFT BUNDLE BRANCH BLOCK AS AN ACTIVATION 

CRITERION FOR PRIMARY PERCUTANEOUS CORONARY 

INTERVENTION: WHERE IS THE EVIDENCE? 

Brown, AJ 

Papworth Hospital 

027 PERCUTANEOUS CORONARY INTERVENTION IN 

OCTOGENARIANS: RESULTS FROM A HIGH VOLUME CENTRE 

Showkathali, R 

Essex Cardiothoracic Centre 

028 AGE RELATED MORTALITY OF PRIMARY PCI PATIENTS AT A 

HIGH VOLUME UK CARDIAC CENTRE 

Malik, N 

Essex Cardiothoracic Centre 

029 MANAGEMENT AND OUTCOMES OF PATIENTS FOLLOWING 

OUT-OF-HOSPITAL CARDIAC ARREST 

Saidmeerasah, A 

James Cook University Hospital 

030 MANAGEMENT OF BIFURCATION DISEASE WITH A DEDICATED 

SIDE-BRANCH DEVICE; A SINGLE CENTRE EXPERIENCE WITH 

THE TRYTON STENT 

Venugopal, V 

Royal Wolverhampton Hospital NHS Trust 

031 USE OF THE NOVEL SIDEGUARD DEDICATED BIFURCATION 

STENT: A REAL WORLD EXPERIENCE 

Sastry, S 

Manchester Royal Infirmary 



032 LACK OF GENDER DIFFERENCE AND IMPROVED IN-HOSPITAL 

MORTALITY RATES IN PATIENTS WITH CARDIOGENIC 

SHOCK FOLLOWING PRIMARY PERCUTANEOUS CORONARY 

INTERVENTION: A UK TERTIARY CARDIAC CENTRE REGISTRY 

STUDY 

Kunadian, V 

Newcastle University 

033 OUT-OF-HOURS MORTALITY IN THE CURRENT PRIMARY 

PERCUTANEOUS CORONARY INTERVENTION ERA 

Noman, A 

Freeman Hospital 

034 THE EFFECT OF THROMBUS ASPIRATION DURING PRIMARY 

PERCUTANEOUS CORONARY INTERVENTION ON IN- 

HOSPITAL MORTALITY AND THROMBOLYSIS IN MYOCARDIAL 

INFARCTION FLOW GRADE 

Noman, A 

Freeman Hospital 

035 THROMBECTOMY AND PLATELET GLYCOPROTEIN IIB/IIIA 

BLOCKADE FOR STENT THROMBOSIS 

Akhtar, M M 

Barts and The London NHS Trust 

036 NO DIFFERENCE IN LONG-TERM MAJOR ADVERSE CARDIAC 

EVENT RATES BETWEEN PACLITAXEL-ELUTING AND 

SIROLIMUS-ELUTING STENTS 

Abu-Own, HA 

London Chest Hospital 

037 DRUG ELUTING STENTS (DES) OFFER BENEFIT OVER BARE 

METAL STENTS (BMS) INSERTED DURING VEIN GRAFT PCI 

Guttmann, OP 


038 DRUG ELUTING STENT IMPLANTATION IS ASSOCIATED 

WITH LOWER MACE RATES THAN BARE METAL STENT 

IMPLANTATION IN PRIMARY PCI FOR ST ELEVATION 

MYOCARDIAL INFARCTION 

Bromage, DI 

Barts and The London NHS Trust

039 OUTCOMES FOLLOWING UNPROTECTED LEFT MAIN 

STENTING WITH FIRST VERSUS SECOND GENERATION 

DRUG-ELUTING STENTS: THE MILAN EXPERIENCE 

Buchanan, GL 

San Raffaele Scientific Institute 

040 OUTCOMES FOLLOWING TRANSCATHETER AORTIC VALVE 

IMPLANTATION COMPARING EDWARDS SAPIEN WITH 

MEDTRONIC COREVALVE REVALVING SYSTEM DEVICES: 

RESULTS FROM THE MILAN REGISTRY 

Buchanan, GL 

San Raffaele Scientific Institute 

041 SERIAL CHANGE IN HEALTH RELATED QUALITY OF LIFE OVER 

ONE YEAR FOLLOWING TRANSCATHETER AORTIC VALVE 

IMPLANTATION: PREDICTORS OF HEALTH OUTCOMES 

Fairbairn, T A 

University of Leeds 

042 ASSESSMENT OF VALVE HAEMODYNAMICS, REVERSE 

VENTRICULAR REMODELLING AND MYOCARDIAL FIBROSIS 

FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION 

COMPARED TO SURGICAL AORTIC VALVE REPLACEMENT. A 

CARDIOVASCULAR MAGNETIC RESONANCE STUDY 

Fairbairn, T A 


043 LOW PACING RATE ACHIEVED IN COREVALVE 

TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI): 

COMPARSION OF PACING RATE PRE AND POST NEW 

DELIVERY CATHETER 

Drury-Smith, M 

Heart and Lung Centre, New Cross Hospital 

044 ENDOVASCULAR & TRANSCATHETER MANAGEMENT OF 

COARCTATION-RELATED ANEURYSMS IN ADULTS 

Khavandi, A 




045 SOCIO-ECONOMIC STATUS AND OUTCOME AFTER 

PERCUTAENOUS CORONARY INTERVENTION 

Jones, DA 

Barts and the London NHS trust 

046 IMPACT OF INCOMPLETE REVASCULARISATION IN PATIENTS 

UNDERGOING PCI FOR UNPROTECTED LEFT MAIN STEM 

STENOSIS 

Malkin, CJ 

Sheffield Teaching Hospitals 

047 TRENDS IN ACCESS SITE CHOICE AND PCI OUTCOMES – 

INSIGHTS FROM THE UK NATIONAL PCI DATASET 

Ratib, K 

University Hospital of North Staffordshire 

048 IS IT SAFE TO DISCHARGE PATIENTS 24 HOURS AFTER 

UNCOMPLICATED SUCCESSFUL PRIMARY PERCUTANEOUS 

CORONARY INTERVENTION? 

Howard, J P 

Barts and the London NHS Trust 

049 THE ROLE OF THE NEURAL NETWORKS IN IDENTIFICATION 

AND ABLATION OF PULMONARY VEIN ECTOPIC TRIGGERS 

Malcolme-Lawes, L 


050 AUTOMATED ANALYSIS OF ATRIAL DELAYED ENHANCEMENT 

CARDIAC MRI CORRELATES WITH VOLTAGE, AF RECURRENCE 

POST-ABLATION, AND HIGH STROKE RISK 

Malcolme-Lawes, L 


051 ORGANISATIONAL INDEX IS THE BEST ASSESSMENT OF 

FRACTIONATION IN PERSISTENT ATRIAL FIBRILLATION: 

ANALYTIC COMPARISONS AND ABLATION RESULTS. 

Finlay, MC 

UCL, The Heart Hospital

052 THE PREVALENCE OF LEFT ATRIAL APPENDAGE 

THROMBUS IN PATIENTS UNDERGOING CATHETER 

ABLATION FOR ATRIAL FIBRILLATION MAINTAINED ON 

WARFARIN 

Herring, N 

John Radcliffe Hospital 

053 FACTORS AFFECTING QUALITY OF WARFARIN 

ANTICOAGULATION IN PATIENTS WITH ATRIAL 

FIBRILLATION: INSIGHTS FROM AFFIRM 

Apostolakis, S 

Centre for Cardiovascular Sciences, University of Birmingham 

054 LEFT VENTRICULAR GEOMETRY AND OUTCOME IN 

PATIENTS WITH ATRIAL FIBRILLATION: INSIGHTS FROM THE 

AFFIRM TRIAL 

Apostolakis, S 


055 SUCCESSFUL APPLICATION OF A NOVEL RESTITUTION 

GRADIENT BASED MARKER OF VENTRICULAR ARRHYTHMIA 

TO PATIENTS WITH NON-ISCHAEMIC CONDITIONS 

Smith, M.I 

University of Leicester 

056 LEUKOCTE TELOMERE/TELOMERASE DYNAMICS IN PATIENTS 

WITH IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; 

POTENTIAL BIOMARKER FOR VENTRICULAR ARRHYTHMIAS 

Sawhney, VS 

St Bartholomew’s Hospital 

057 A RANDOMISED CONTROLLED TRIAL OF CATHETER ABLATION 

VERSUS MEDICAL TREATMENT OF ATRIAL FIBRILLATION IN 

HEART FAILURE (THE CAMTAF TRIAL) 

Hunter, RJ 

St Bartholomew’s Hospital 



058 THE RELATIONSHIP OF LEFT ATRIAL REMODELLING TO 

ATRIAL FIBRILLATION BURDEN IN PACEMAKER POPULATION 

Khoo, CW 

University Department of Medicine Centre for Cardiovascular 

Sciences, City Hospital 

059 PACEMAKER IMPLANTATION USING REAL-TIME ULTRASOUND 

GUIDANCE FOR SUBCLAVIAN VEIN ACCESS 

Darlington, EL 

Wirral University Teaching Hospital 

060 THE PRACTICE AND PERCEPTION OF TRANSVENOUS LEAD 

EXTRACTION IN THE UK – LESSONS FROM A NATIONWIDE 

SURVEY 

Sohal, M 

Guy’s and St Thomas’ NHS Foundation Trust 

061 QT PROLONGATION ASSOCIATES WITH INCREASED 

MORTALITY IN PATIENTS WITH RHEUMATOID ARTHRITIS 

Panoulas, VF 

Hammersmith Hospital, Imperial Healthcare NHS Trust 

062 RE-APPRAISAL OF ECG INTERPRETATION IN YOUNG 

ATHLETES: SHOULD AXIS DEVIATION AND VOLTAGE 

CRITERION FOR ATRIAL ENLARGMENT BE CATEGORISED AS 

ABNORMAL IN ATHLETES? THE BRITISH EXPERIENCE 

Gati, S 

St George’s University of London 

063 SEX AND ETHNICITY SPECIFIC ECG DIFFERENCES IN 

ELITE ATHLETES: RELEVANCE TO PRE-PARTICIPATION 

CARDIOVASCULAR EVALUATION – THE BRITISH EXPERIENCE 

Gati, S 

St George’s Univeristy of London 

064 PREVALENCE AND MORPHOLOGICAL CHARACTERISATION 

OF EARLY REPOLARISATION PATTERNS IN YOUNG HEALTHY 

INDIVIDUALS: IMPACT OF GENDER, ETHNICITY AND 

PHYSICAL ACTIVITY 

Ghani, S 

St George’s University London

065 ATRIAL FIBRILLATION ABLATION IN A DISTRICT 

GENERAL HOSPITAL – 3 YEARS EXPERIENCE 

Furniss, SS 

Eastbourne DGH 

066 ANTI-THROMBOTIC THERAPY AND ATRIAL FIBRILLATION 

IN SCOTLAND: RESULTS OF A NATIONAL AUDIT 

Simpson, J 

Southern General Hospital 

067 ANTICOAGULATION IN PATIENTS WITH ATRIAL 

FIBRILLATION AND A PERMANENT PACEMAKER REMAINS 

POOR AS GENERAL PRACTITIONERS ARE NOT INFORMED 

OF THE ARRHYTHMIA 

Vassiliou, V 

Papworth Hospital 

068 THE VENTRICULAR ECTOPIC QS INTERVAL (VEQSI): 

DIAGNOSIS OF ARRHYTHMOGENIC RIGHT VENTRICULAR 

CARDIOMYOPATHY (ARVC) 

Bastiaenen, R 

St George’s Hospital NHS Trust 

069 SYSTEMATIC REVIEW OF 1142 ADMISSIONS WITH 

ACUTE HEART FAILURE REVEALS HIGH FREQUENCY OF 

TRANSTHYRETIN V122I CARDIAC AMYLOIDOSIS IN AFRO- 

CARIBBEAN PATIENTS 

Dungu, J 

St George’s University of London 

070 ENZYME REPLACEMENT THERAPY IMPROVES CARDIAC 

FEATURES OF FABRY DISEASE 

Motwani, M 

Salford Royal Hospital NHS Foundation Trust 

071 CONCENTRIC HYPERTROPHIC REMODELLING AND 

SUBENDOCARDIAL DYSFUNCTION IN MITOCHONDRIAL DNA 

POINT MUTATION CARRIERS 

Bates, MGD 




072 FRAGMENTED QRS: A PREDICTOR OF MYOCARDIAL SCAR 

AND FIBROSIS IN HYPERTROPHIC CARDIOMYOPATHY 

Sheikh, N 

St. George’s University of London 

073 EVALUATION OF CLINICAL MARKERS OF EARLY DISEASE 

EXPRESSION AND THE ABILITY TO PREDICT GENOTYPE IN 

FAMILIES WITH HCM AND MUTATIONS IN CARDIAC MYOSIN 

BINDING PROTEIN C 

Page, SP 

The Heart Hospital, UCLH 

074 THE PREVALENCE AND SIGNIFICANCE OF LEFT VENTRICULAR 

HYPERTRABECULATION IN HIGHLY TRAINED ATHLETES 

Gati, S 


075 EFFECT OF AORTIC VALVE REPLACEMENT ON LV REMODELING 

AND MATRIX METALLOPROTEINASES AND THEIR TISSUE 

INHIBITORS IN ISOLATED SEVERE AORTIC STENOSIS 

Steadman, CD 


076 FAILURE OF AORTIC VALVE REPLACEMENT TO IMPROVE 

OBJECTIVE FUNCTIONAL CAPACITY IN PATIENTS WITH 

ISOLATED SEVERE AORTIC STENOSIS 

Steadman, CD 


077 OSTEOPOROSIS AND BISPHOSPHONATE’S USE ASSOCIATED 

WITH REDUCED PROGRESSION OF CALCIFIC AORTIC 

STENOSIS: RETROSPECTIVE OBSERVATIONAL SINGLE 

CENTRE STUDY 

Saeed, Y 

University Hospital Aintree NHS trust 

078 A RANDOMISED STUDY OF THE EFFECTS OF BI-LEAFLET 

PROSTHESIS ORIENTATION ON AORTIC HAEMODYNAMICS 

AND CORONARY FLOW VELOCITY PROFILES 

Jin, XY 

Oxford University Hospital NHS Trust

079 OUTCOME OF TRANSCATHETER MITRAL VALVE CLIP 

FOR THE MANAGEMENT OF MITRAL REGURGITATION 

IN HIGH RISK GROUP PATIENTS UNSUITABLE FOR 

SURGICAL INTERVENTION 

KESHAVARZI, F 

CASTLE HILL HOSPITAL 

080 SAFETY OF LMWH FOR BRIDGING ANTICOAGULATION 

BEFORE FULL WARFARINISATION IN MECHANICAL VALVES 

Jones, S G 

St George’s Hospital 

081 ACUTE DERANGEMENT OF CARDIAC ENERGY METABOLISM 

AND OXYGENATION DURING STRESS IN HYPERTROPHIC 

CARDIOMYOPATHY – A POTENTIAL MECHANISM FOR SUDDEN 

CARDIAC DEATH 

Dass, S 

University of Oxford 

082 RIGHT VENTRICULAR HYPERTROPHY AND THE ATHLETE’S 

HEART: UTILITY OF THE ELECTROCARDIOGRAM AS A 

SCREENING TOOL 

Zaidi, A 

St George’s, University of London 

083 ANNULO-APICAL ANGLES AND TAPSE TO RAPIDLY ASSESS 

RIGHT VENTRICULAR 

SYSTOLIC FUNCTION: A CARDIAC MAGNETIC RESONANCE 

STUDY 

Zakeri, Borg, Schmitt, SA, AN, M 

Cardiovascular Division, University Hospital of South Manchester 

084 IN VIVO ASSESSMENT OF CELLULAR INFLAMMATION 

FOLLOWING ACUTE MYOCARDIAL INFARCTION 

Alam, S.R 

Edinburgh University 

085 SYSTOLIC VERSUS DIASTOLIC ACQUISITION IN 

CARDIOVASCULAR MAGNETIC RESONANCE MYOCARDIAL 

PERFUSION IMAGING 

Motwani, M 




086 ASSESSMENT OF ISCHAEMIC BURDEN IN PATIENTS WITH 

THREE-VESSEL CORONARY ARTERY DISEASE USING HIGH- 

RESOLUTION MYOCARDIAL PERFUSION CARDIOVASCULAR 

MAGNETIC RESONANCE IMAGING 

Motwani, M 


087 INCREMENTAL VALUE OF HIGH-RESOLUTION 

CARDIOVASCULAR MAGNETIC RESONANCE MYOCARDIAL 

PERFUSION IMAGING IN SUSPECTED CORONARY ARTERY 

DISEASE 

Motwani, M 


088 COMPARISON OF CARDIOVASCULAR MAGNETIC RESONANCE 

STRESS PERFUSION WITH SINGLE PHOTON EMISSION 

COMPUTED TOMOGRAPHY (SPECT) IN PATIENTS WITH LEFT 

MAIN STEM DISEASE: A CE-MARC SUBSTUDY 

Kidambi, A 

Multidisciplinary Cardiovascular Research Centre & Leeds Institute of 

Genetics, Health and Therapeutics, University of Leeds 

089 REGRESSION OF MYOCARDIAL OEDEMA IS RELATED TO 

IMPROVEMENT IN MYOCARDIAL CONTRACTILITY FOLLOWING 

REPERFUSED ACUTE MYOCARDIAL INFARCTION 

Kidambi, A 

Multidisciplinary Cardiovascular Research Centre & Leeds Institute of 

Genetics, Health and Therapeutics, University of Leeds 

090 PRE-CONTRAST T1 MAPPING ALLOWS ASSESSMENT OF 

SEVERITY OF ACUTE ISCHEMIC MYOCARDIAL INJURY 

Dall’Armellina, E 

OCMR, Dept of Cardiovascular Medicine, John Radcliffe Hospital 

091 T1-MAPPING HAS A HIGH DIAGNOSTIC PERFORMANCE 

IN PATIENTS PRESENTING WITH ACUTE MYOCARDITIS: A 

CARDIOVASCULAR MAGNETIC RESONANCE STUDY 

Ferreira, VM 

University of Oxford

092 INTERSTITIAL EXPANSION IN HEALTH AND DISEASE – 

AN EQUILIBRIUM CONTRAST CMR STUDY 

Sado, DM 

The Heart Hospital 

093 CARDIAC INVOLVEMENT IN CARDIAC AL AMYLOIDOSIS 

AS MEASURED BY EQUILIBRIUM CONTRAST 

CARDIOVASCULAR MAGNETIC RESONANCE 

Banypersad, SM 

The Heart Hospital 

094 THE PREVALENCE OF NON-CALCIFIED PLAQUES IN 

SYMPTOMATIC PATIENTS WITH ZERO CALCIUM SCORE 

Koulaouzidis, GK 

Heart Centre and Department of Public Health and Clinical Medicine, 

Umea University 

095 PLAQUE MAPPING BASED ON CONTRAST RATIOS PERMITS 

IDENTIFICATION OF UNSTABLE CORONARY PLAQUE AND 

QUANTIFICATION OF CORONARY ATHEROSCLEROSIS BY 

CORONARY CT ANGIOGRAPHY 

Obaid, DR 

University of Cambridge 

096 A COMPARATIVE STUDY OF STANDARD FILTERED BACK 

PROJECTION WITH NOVEL ITERATIVE RECONSTRUCTION 

TECHNIQUES IN CARDIAC CT 

McKavanagh, P 

Ulster Hospital 

097 CALCIUM SCORES ARE MORE COST EFFECTIVE FOR 

RISK STRATIFICATION THAN NICE’S MODIFIED DIAMOND 

FORRESTER CALCULATOR 

McKavanagh, P 

Ulster Hospital 

098 QUANTITATIVE CARDIOVASCULAR MAGNETIC RESONANCE 

MYOCARDIAL PERFUSION IMAGING: INTER-STUDY 

REPRODUCIBILITY 

Morton, G 




099 DYNAMIC THREE-DIMENSIONAL WHOLE HEART MAGNETIC 

RESONANCE MYOCARDIAL PERFUSION IMAGING: VALIDATION 

AGAINST THE DUKE JEOPARDY SCORE TO ASSESS 

MYOCARDIUM AT RISK 

Jogiya, R 


100 DIAGNOSTIC ACCURACY OF HIGH DEFINITION COMPUTED 

TOMOGRAPHIC CORONARY ANGIOGRAPHY COMPARED TO 

INVASIVE CORONARY ANGIOGRAPHY IN THE ASSESSMENT 

OF PATIENTS WITH HIGH PRE-TEST PROBABILITY OF OR 

ESTABLISHED CORONARY ARTERY DISEASE 

Iyengar, S 

Plymouth Hospital NHS Trust 

101 INCORPORATION OF STRESS ECHOCARDIOGRAPHY INTO 

AN ACUTE CHEST PAIN SERVICE PROVIDES EXCELLENT 

FEASIBILITY, EARLY TRIAGING & ACCURATE RISK 

STRATIFICATION OF PATIENTS WITH SUSPECTED ACUTE 

CORONARY SYNDROME BUT NON-DIAGNOSTIC ECG & 

NORMAL 12-HR TROPONIN 

Shah, BN 

Northwick Park Hospital & Royal Brompton Hospital 

102 POCKET-SIZE HAND-HELD CARDIAC ULTRASOUND IN THE 

HANDS OF STUDENTS AND JUNIOR DOCTORS: DOES IT 

IMPROVE DIAGNOSTIC ACCURACY OVER HISTORY, PHYSICAL 

EXAMINATION AND ECG? 

Panoulas, VF 

Hammersmith Hospital, Imperial Healthcare NHS Trust 

103 AORTIC INFLAMMATION IS REDUCED, AND PARALELLES 

CHANGES IN AORTIC STIFFNESS BY ANTI-TNF ALPHA 

THERAPY IN RHEUMATOID ARTHRITIS 

Maki-Petaja, K M 


104 ENHANCING ENDOTHELIAL INSULIN SENSITIVITY 

REDUCES NITRIC OXIDE BIOAVAILABILITY: A ROLE 

FOR NADPH OXIDASE-DERIVED REACTIVE OXYGEN 

SPECIES 

Viswambharan, H 


105 NOX 2 NADPH - OXIDASE A NOVEL TARGET TO PREVENT 

INSULIN RESISTANCE RELATED ENDOTHELIAL CELL 

DYSFUNCTION 

Sukumar, P 


106 ROLE OF NEURONAL VERSUS ENDOTHELIAL NITRIC OXIDE 

SYNTHASE IN THE CORONARY BLOOD FLOW RESPONSE TO 

PACING 

Shabeeh, H 

King’s College London British Heart Foundation Centre of Research 

Excellence 

107 REMOTE ISCHAEMIC PRECONDITIONING AND HUMAN ATRIAL 

TRABECULAE IN THE DIABETIC HEART 

Candilio, L 

The Hatter Cardiovascular Institute 

108 REMOTE ISCHAEMIC CONDITIONING IS IMPAIRED IN 

DIABETES. 

EDROOS, SA 

University of Leicester Department of Cardiovascular Sciences 

109 OVEREXPRESSION OF ENDOTHELIAL INSULIN-LIKE GROWTH 

FACTOR-1 RECEPTORS (IGF-1R): A NOVEL ROLE FOR IGF-1R 

IN ENDOTHELIAL FUNCTION AND REPAIR 

Imrie, H 


110 LOCAL BETA-ADRENERGIC STIMULATION OVERCOMES 

SOURCE-SINK MISMATCH TO GENERATE FOCAL 

ARRHYTHMIA 

Myles, RC 

University of Glasgow 



111 ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY- 

LIKE PHENOTYPE REVEALED BY ENDURANCE TRAINING IN 

HETEROZYGEOUS DESMOGLEIN2 MUTANTS 

Fabritz, L 


112 LOCATION OF SUBSIDIARY ATRIAL PACEMAKERS FOLLOWING 

ABLATION OF THE SINUS NODE IN THE GOAT 

Borbas, Z 

University of Manchester 

113 BLOOD THROMBOGENICITY IS INVERSELY RELATED TO 

CORONARY LESION SEVERITY IN PATIENTS WITH NON ST- 

ELEVATION ACUTE CORONARY SYNDROME AND TYPE 2 

DIABETES MELLITUS 

Balasubramaniam, K 


114 WHOLE GENOME SEQUENCING TO IDENTIFY GENETIC 

VARIANTS UNDERLYING CARDIOVASCULAR DISEASE 

AMONGST INDIAN ASIANS 

Chambers, JC 


115 UNIQUE CHARACTERISTICS OF CD14++CD16+ MONOCYTES 

IN PATIENTS WITH ACUTE HEART FAILURE AND IMPLICATIONS 

FOR CLINICAL OUTCOME 

Wrigley, B J 

University of Birmingham Centre for Cardiovascular Sciences 

116 MATRIX METALLOPROTEINASE INHIBITION ATTENUATES 

REPERFUSION INJURY, INDEPENDENTLY OF AND ADDITIVE TO 

MITOCHONDRIAL PERMEABILITY TRANSITION PORE INHIBITION 

Bell, RM 

Hatter Cardiovascular Institute, University College London

117 CONDUCTION BLOCK INDUCED BY ACIDOSIS IN 

HL-1 MOUSE ATRIAL MYOCYTES CAN BE REVERSED 

BY ADMINISTERING THE GAP JUNCTIONAL COUPLER 

ROTIGAPTIDE 

Al-Aidarous, SI 


118 FIRST PASS VASODILATOR-STRESS MYOCARDIAL 

PERFUSION CMR IN MICE ON A CLINICAL WHOLE-BODY 

3TESLA SCANNER: VALIDATION AGAINST MICROSPHERES 

Jogiya, R 


119 SIZE-DEPENDENT RETENTION OF STEM CELLS FOLLOWING 

INTRACORONARY INJECTION 

Campbell, NG 

William Harvey Research Institute, Queen Mary University of London 

120 BLOOD FLOW IS REQUIRED FOR ENDOTHELIAL REPAIR IN A 

NOVEL IN VIVO MODEL USING ZEBRAFISH EMBRYOS 

Quaife, NM 

MRC Centre for Developmental and Biomedical Genetics, University 

of Sheffield 

121 BIOINFORMATIC IMAGING AND MOLECULAR INVESTIGATION 

FOR A ROLE OF P22PHOX C242T POLYMORPHISM IN 

INHIBITING ENDOTHELIAL ROS PRODUCTION 

Meijles, DN 

University of Surrey 

122 AN INTERVENTION TO ALTER HELP-SEEKING BEHAVIOUR 

AND REDUCE PRE-HOSPITAL DELAY TIME IN PATIENTS 

DIAGNOSED WITH ACUTE CORONARY SYNDROME (ACS) 

Mooney, M 

Trinity College Dublin 

123 IRISH PATIENTS’ PERCEPTIONS OF THEIR RISK FOR 

A HEART ATTACK IN THE FUTURE FOLLOWING THE 

DIAGNOSIS OF ACUTE CORONARY SYNDROME 

O’Brien, F 

Trinity College Dublin 



124 IMPACT OF CONTRAST-INDUCED NEPHROPATHY UPON 

SHORT AND LONG-TERM OUTCOMES OF PATIENTS WITH 

ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION 

UNDERGOING PRIMARY PERCUTANEOUS CORONARY 

INTERVENTION 

Gallagher, Sean 

Barts and the London NHS Trust 

125 MONOCYTE SUBPOPULATION COUNTS AND FUNCTIONAL 

CHARACTERISTICS PREDICT ADVERSE CLINICAL EVENTS 

POST ST ELEVATION MYOCARDIAL INFARCTION 

Ghattas, AA 

Centre for Cardiovascular Sciences University of Birmingham 

126 DYNAMICS OF THE THREE HUMAN MONOCYTE SUBSETS 

OVER 30 DAYS IN ST-ELEVATION MYOCARDIAL INFARCTION 

Tapp, LD 

City Hospital 

127 DEMONSTRATION OF INTRACORONARY MICROPARTICLE 

EXPRESSION AND THEIR ASSOCIATION WITH ACTIVATED 

PLATELET MONOCYTE AGGREGATE IN HUMAN ST ELEVATION 

MYOCARDIAL INFARCTION 

Mavroudis, C A 

Royal Free Hospital 

128 IMPLICATIONS OF LOWERING THE THRESHOLD OF CARDIAC 

TROPONIN IN THE DIAGNOSIS OF MYOCARDIAL INFARCTION 

Lee, KK 

Centre for Cardiovascular Science, Edinburgh University 

129 THE PROGNOSTIC VALUE OF A SEVEN WEEK HIGH 

SENSITIVITY TROPONIN T LEVEL AFTER AN ACUTE 

CORONARY SYNDROME 

Ang, DS 

University of Dundee 

130 PRIOR CORONARY ARTERY BYPASS GRAFT PATIENTS TREATED 

WITH PRIMARY PERCUTANEOUS CORONARY INTERVENTION 

HAVE HIGHER LONG-TERM ADVERSE EVENT RATES 

Hamshere, SM 

London Chest Hospital

131 MULTIVESSEL CORONARY DISEASE IN 

PRIMARY PERCUTANEOUS INTERVENTION. 

REVASCULARISATION STRATEGY AND ITS IMPACT ON 

MEDIUM TERM MORTALITY 

Alahmar, A E 

Glenfield Hospital, University Hospitals of Leicester NHS Trust 

132 COMBINED PRASUGREL & BIVALIRUDIN TREATMENT 

DURING PRIMARY PCI OFFERS A SAFE AND EFFECTIVE 

STRATEGY IN ST-ELEVATION MI 

Johnson, TW 


133 CORONARY WAVE INTENSITY: A NOVEL INVASIVE TOOL FOR 

PREDICTING MYOCARDIAL VIABILITY FOLLOWING ACUTE 

CORONARY SYNDROMES 

De Silva, K 

St. Thomas’ Hospital/King’s College London 

134 THE ROLE OF CARDIOVASCULAR MAGNETIC RESONANCE 

IMAGING IN TROPONIN POSITIVE ACUTE CORONARY 

SYNDROMES WITH UNOBSTRUCTED CORONARY ARTERIES 

McAlindon, E 


135 CHRONIC DPP-4 INHIBITION BY SITAGLIPTIN ENHANCES 

BOTH GLOBAL AND REGIONAL MYOCARDIAL FUNCTION 

DURING DOBUTAMINE STRESS IN PATIENTS WITH TYPE 2 

DIABETES MELLITUS AND CORONARY ARTERY DISEASE 

McCormick, LM 

Department of Cardiovascular Medicine, University of Cambridge 

136 INCREASE IN LEFT VENTRICULAR MASS IN TYPE 2 DIABETES 

IS DEPENDENT ON DURATION OF DIABETES 

Ghosh, AK 


137 TIME FOR A REVIEW OF THE ‘WATCH AND WAIT’ STRATEGY 

FOR YOUNG BORDERLINE-HYPERTENSIVES? 

Ghosh, AK 




138 NON-ANGINAL CHEST PAIN: NOT AS BENIGN AS WE WOULD 

LIKE TO BELIEVE! 

George, A 

Scunthorpe General Hospital 

139 CLINICAL OUTCOMES OF PATIENTS EXCLUDED FROM 

CARDIAC INVESTIGATION IN THE NICE GUIDELINES FOR 

CHEST PAIN OF RECENT ONSET 

Patterson, C 

Imperial College, London 

140 ASSESSMENT OF PRE-TEST LIKELIHOOD OF CORONARY 

ARTERY DISEASE IN PATIENTS WITH CHEST PAIN OF 

RECENT ONSET 

Haq, I U 

Royal Victoria Infirmary 

141 CARDIAC TROPONIN REFLECTS SILENT MYOCARDIAL 

ISCHAEMIA IN PATIENTS WITH STABLE CORONARY ARTERY 

DISEASE 

Shah, ASV 

Royal Infirmary of Edinburgh 

142 ONSET OF PREECLAMPSIA IS PRECEDED BY STRUCTURAL 

CAPILLARY RAREFACTION 

Antonios, TFT 

Blood Pressure Unit & Department of Clinical Sciences, St. George’s, 

University of London 

143 LONG-TERM CARDIAC AND VASCULAR PHENOTYPE OF 

YOUNG WOMEN WITH PREGNANCIES COMPLICATED BY PRE- 

ECLAMPSIA 

Lazdam, M 

University of Oxford 

144 NURSES MEET THE CHALLENGE OF HELPING HIGH CVD RISK 

SMOKERS TO QUIT WITH THE HELP OF VARENICLINE IN A 

PREVENTIVE CARDIOLOGY PROGRAMME 

Jennings, CS 

Imperial College London

145 EUROACTION PLUS: A RANDOMISED CONTROLLED 

TRIAL ON PREVENTIVE CARDIOLOGY PROGRAMME 

PLUS INTENSIVE SMOKING CESSATION WITH 

VARENICLINE FOR VASCULAR AND HIGH CVD RISK 

SMOKERS AND THEIR PARTNERS- PRINCIPAL RESULTS 

Kotseva, K 

National Heart & Lung Institute, Imperial College London 

146 B-TYPE NATRIURETIC PEPTIDE AND CORONARY 

ATHEROSCLEROSIS: AN ASSOCIATION DEPENDENT ON 

CENTRAL PULSE PRESSURE 

Kotecha, D 

Royal Berkshire Hospital 

147 POST CHALLENGE HYPERGLYCEMIA: A PREDICTOR OF POOR 

CARDIOVASCULAR OUTCOME IN PATIENTS WITH ACS 

GEORGE, ANISH 

SCUNTHORPE GENERAL HOSPITAL 

148 INSULIN DEPENDENT DIABETES RESULTS IN WORSE 

OUTCOMES COMPARED TO NON-INSULIN DEPENDENT 

DIABETES FOLLOWING CORONARY ARTERY BYPASS GRAFT 

SURGERY (CABG) 

Rathod, KS 


149 ETHNIC DIFFERENCES IN PERFORMANCE OF THE 2010 

EUROPEAN SOCIETY OF CARDIOLOGY CRITERIA FOR ECG 

INTERPRETATION IN ATHLETES 

Sheikh, N 


150 ‘HEART TEAM’ DECISION MAKING IN THE MANAGEMENT OF 

PATIENTS WITH CORONARY ARTERY DISEASE; STRUCTURE, 

OUTCOMES AND REPRODUCIBILITY 

Tapp, LD 

New Cross Hospital 



151 NUCLEAR MAGNETIC RESONANCE PROFILING OF SERUM 

IDENTIFIES NOVEL BIOMARKER ASSOCIATED WITH 

CORONARY ATHEROSCLEROSIS 

Tan, ST 


BAS/BSCR Abstracts / Posters 

BSCR/BAS Young Investigator Award 

BAS001 TRISTETRAPROLIN POST-TRANSCRIPTIONALLY REGULATES 

TISSUE FACTOR EXPRESSION IN PRIMARY HUMAN AND 

MURINE MACROPHAGES 

M. B. Iqbal 

Vascular Sciences Section, National Heart and Lung Institute, 

Hammersmith Hospital, Imperial College London 

BAS002 NANOPARTICLES FOR SIMULTANEOUS CELL TRACKING & 

MICRORNA DELIVERY 

Gomes, R.S.M 

Biomaterials & Stem Cells Based Therapeutics Lab, Portugal; Centre 

of Neurosciences and Cell Biology, University of Coimbra, Portugal; 

Cardiovascular Biology & Medicine, University College London; 

Cardiac Metabolism Research Group, Oxford University, UK 

BAS003 TISSUE TRAIL DRIVES PULMONARY VASCULAR REMODELING 

AND IT’S INHIBITION REVERSES EXPERIMENTAL PULMONARY 

ARTERIAL HYPERTENSION 

Hameed A.G 

Department of Cardiovascular Science, University of Sheffield 

BAS004 THE CARDIAC EXTRACELLULAR MATRIX IS REMODELLED 

DIVERGENTLY WITH AGE IN HEART FAILURE: A ROLE FOR 

ALTERED COLLAGEN DEGRADATION IN AN OVINE RAPID 

PACING MODEL 

Horn MA 

Unit of Cardiac Physiology, The University of Manchester

BAS005 NOX2-DERIVED OXIDATIVE STRESS AND BONE 

MARROW-DERIVED HEMATOPOIETIC STEM CELL 

DYSFUNCTION IN MIDDLE-AGE OBESITY 

Meijles DN 

FHMS, University of Surrey, Guildford 

BAS006 DUAL ENERGY CT HAS THE POTENTIAL TO IMPROVE NON- 

INVASIVE IDENTIFICATION OF NECROTIC CORE 

Obaid D 

Dept of Cardiovascular Medicine, University of Cambridge 


Notes


Notes


Notes


Notes

Sometimes the best 

medicine is less. 

That’s why Boston Scientifi c is investing $1 billion 

annually to develop less-invasive medical devices 

and procedures that can reduce risk, trauma and 

treatment cost. 

For more than 30 years, Boston Scientifi c has built its 

global leadership by helping doctors like you improve 

lives with innovative medical technology solutions. Like 

you, we’re working to address unmet clinical needs and 

to reduce the frequency of patient re-intervention. That’s 

the commitment to innovation we’re making to you. 

Learn more at www.bostonscientifi c.com/innovation 

Boston Scientifi c is advancing patient care in a variety 

of medical areas, including: Cancer • Chronic Pain 

Digestive Disorders• Heart Conditions • Lung and Airway 

Conditions • Urological Conditions • Vascular Disease 

Women’s Health Conditions 

Copyright © 2012 by Boston Scientifi c Corporation or its 2012 affi liates. Annual All rights Conference reserved. and Exhibition CORP-63303-AA p115 

MAR2012

STROKE 

NICE 

SMC 

RECOMMENDED BY 

ACCEPTED BY 

Please refer to the SPC before prescribing this product, particularly in relation to 

side-effects, precautions and contra-indications. 

Adverse events should be reported. Reporting forms and 

information can be found at www.mhra.gov.uk/yellowcard. 

Adverse events should also be reported to Boehringer Ingelheim 

Drug Safety on 0800 328 1627 (freephone). 

Legal category: POM 

Further information is available from: Boehringer Ingelheim Limited, 

Ellesfield Avenue, Bracknell, Berkshire. RG12 8YS 

For an educational pack, go to www.pradaxa.co.uk/SPAFeducationalpack 

or call the Pradaxa ® information line on 0845 601 7880 

Date of preparation: April 2012 Job code: UK/DBG-121251 

PREVENTION 

The first new oral anticoagulant 

for stroke prevention in 

atrial fibrillation in 50 years 

Pradaxa ® For prevention of stroke and systemic 

embolism in adult patients with nonvalvular 

atrial fibrillation with one or more of the following 

risk factors: 

• Previous stroke, transient ischaemic attack or 

systemic embolism (SEE) 

• Left ventricular ejection fraction

Annual Conference and Exhibition Programme - British ...

Create successful ePaper yourself

Delete template?

Save as template?